https://curecurrent.com/trials/a-phase-i-placebo-controlled-dose-escalation-study-of-the-safety-tolerability-and-pharmacokinetics-of-thalidomide-in-sub-129009https://curecurrent.com/trials/pilot-study-to-evaluate-the-efficacy-of-zidovudine-in-preventing-cd4-lymphocyte-decline-in-patients-with-primary-hiv-inf-129010https://curecurrent.com/trials/treatment-success-and-failure-in-hiv-infected-subjects-receiving-indinavir-in-combination-with-nucleoside-analogs-a-roll-129011https://curecurrent.com/trials/a-double-blind-placebo-controlled-trial-of-the-safety-and-immunogenicity-of-a-seven-valent-pneumococcal-conjugate-vaccin-129012https://curecurrent.com/trials/a-study-to-test-the-effect-of-cyclosporine-on-the-immune-system-of-patients-with-early-hiv-disease-129013https://curecurrent.com/trials/phase-ii-randomized-open-label-trial-of-atovaquone-plus-pyrimethamine-and-atovaquone-plus-sulfadiazine-for-the-treatment-129014https://curecurrent.com/trials/the-use-of-chemotherapy-plus-radiotherapy-plus-azidothymidine-in-patients-with-aids-related-lymph-node-cancer-129015https://curecurrent.com/trials/a-multicenter-phase-ii-double-blind-exploratory-study-to-evaluate-differences-among-various-zidovudine-didanosine-regime-129016https://curecurrent.com/trials/a-phase-i-ii-open-labelled-trial-of-intravitreal-ganciclovir-salvage-therapy-for-aids-patients-with-active-cmv-retinitis-129017https://curecurrent.com/trials/a-pilot-study-evaluating-penicillin-g-and-ceftriaxone-as-therapies-for-presumed-neurosyphilis-in-hiv-seropositive-indivi-129018https://curecurrent.com/trials/phase-ii-study-of-filgrastim-g-csf-plus-abvd-in-the-treatment-of-hiv-associated-hodgkin-s-disease-129019https://curecurrent.com/trials/dot-diary-optimization-pilot-a-pilot-study-to-optimize-the-dot-diary-app-to-measure-prep-adherence-129020https://curecurrent.com/trials/phase-i-safety-and-immunogenicity-trial-of-vaccinia-hiv-envelope-recombinant-vaccine-hivac-1e-in-combination-with-solubl-129021https://curecurrent.com/trials/an-assessment-of-the-in-vivo-biological-effects-of-diethyldithiocarbamate-dtc-in-hiv-infected-patients-129022https://curecurrent.com/trials/barbershop-talk-hiv-prevention-for-african-american-heterosexual-men-129023https://curecurrent.com/trials/an-open-trial-combining-zidovudine-interferon-alfa-and-recombinant-cd4-igg-with-transplantation-of-syngeneic-bone-marrow-129024https://curecurrent.com/trials/planning-the-mpact-trial-mhealth-strategies-for-the-pediatric-to-adult-hiv-care-transition-129025https://curecurrent.com/trials/a-trial-of-two-doses-of-2-3-dideoxycytidine-ddc-in-the-treatment-of-children-with-symptomatic-hiv-infection-who-are-into-129026https://curecurrent.com/trials/safety-and-efficacy-of-doravirine-tenofovir-lamivudine-mk-1439a-in-participants-infected-with-treatment-na-ve-human-immu-129027https://curecurrent.com/trials/safety-and-effectiveness-of-an-adjuvant-in-improving-immune-response-to-hepatitis-b-virus-vaccine-in-hiv-infected-indivi-129028https://curecurrent.com/trials/evaluation-of-the-safety-tolerability-and-pharmacokinetics-pk-of-gsk3732394-first-time-in-human-ftih-study-129029https://curecurrent.com/trials/blood-levels-of-tenofovir-gel-in-hiv-uninfected-pregnant-women-planning-cesarean-delivery-129030https://curecurrent.com/trials/pharmacokinetic-study-of-dapivirine-gel-administered-rectally-to-hiv-1-seronegative-adults-129031https://curecurrent.com/trials/safety-and-pharmacokinetics-of-intravaginal-rings-containing-vicriviroc-mk-4176-and-or-mk-2048-129032https://curecurrent.com/trials/tenofovir-gel-in-pregnancy-and-lactation-129033https://curecurrent.com/trials/link4health-a-combination-strategy-for-linkage-and-retention-swaziland-129034https://curecurrent.com/trials/hpv-infection-and-cervical-lesions-in-hiv-infected-women-in-thailand-a-prospective-study-129035https://curecurrent.com/trials/immunogenicity-and-safety-of-an-inactivated-covid-19-vaccine-in-people-aged-18-years-with-hiv-infected-129036https://curecurrent.com/trials/perinatal-antiretroviral-intensification-for-pmtct-of-hiv-in-late-comers-129037https://curecurrent.com/trials/immunogenicity-and-safety-of-an-inactivated-covid-19-vaccine-in-people-with-hiv-infected-129038https://curecurrent.com/trials/effects-of-crofelemer-on-the-gut-microbiome-in-healthy-volunteers-and-in-hiv-patients-with-non-infectious-diarrhea-129039https://curecurrent.com/trials/rapid-test-and-treat-dolutegravir-plus-lamivudine-study-in-newly-diagnosed-human-immunodeficiency-virus-hiv-1-infected-a-129040https://curecurrent.com/trials/inflammatory-pathogenesis-of-coronary-atherosclerosis-in-hiv-129041https://curecurrent.com/trials/switch-to-maraviroc-integrase-inhibitor-129042https://curecurrent.com/trials/immune-response-to-bcg-vaccination-in-neonates-born-to-hiv-and-ltbi-infected-and-non-infected-mothers-129043https://curecurrent.com/trials/immunogenicity-and-safety-of-covid-19-vaccine-in-people-living-with-hiv-129044https://curecurrent.com/trials/individualized-cognitive-training-in-hiv-129045https://curecurrent.com/trials/safety-and-pharmacokinetic-study-of-dapivirine-gel-0-05-administered-rectally-to-hiv-1-seronegative-adults-129046https://curecurrent.com/trials/evaluating-the-safety-pharmacokinetics-and-antiviral-activity-of-a-human-monoclonal-antibody-vrc01-in-hiv-infected-adult-129047https://curecurrent.com/trials/adherence-and-acceptability-to-and-blood-levels-of-tenofovir-gel-and-tablets-in-hiv-uninfected-women-129048https://curecurrent.com/trials/evaluating-the-safety-tolerability-and-pharmacokinetics-of-an-investigational-injectable-hiv-medicine-gsk1265744-in-hiv-129049https://curecurrent.com/trials/safety-and-effectiveness-of-hiv-1-dna-plasmid-vaccine-and-hiv-1-recombinant-adenoviral-vector-vaccine-in-hiv-uninfected-129050https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-a-prime-boost-vaccine-regimen-of-geo-d02-dna-and-mva-hiv62b-with-and-without-129051https://curecurrent.com/trials/evaluating-the-safety-and-immune-response-to-different-combinations-of-the-dna-hiv-pt123-and-aidsvax-b-e-vaccines-in-hea-129052https://curecurrent.com/trials/evaluating-the-safety-and-drug-levels-of-an-antibody-against-hiv-in-healthy-hiv-uninfected-adults-129053https://curecurrent.com/trials/evaluating-the-safety-and-immune-response-to-five-different-combinations-of-hiv-vaccines-in-healthy-hiv-uninfected-adult-129054https://curecurrent.com/trials/the-effectiveness-of-human-antibodies-in-influencing-an-aids-like-disease-in-monkeys-129055https://curecurrent.com/trials/evaluating-the-safety-and-immune-response-to-two-hiv-vaccine-regimens-in-healthy-hiv-uninfected-adults-in-the-united-sta-129056https://curecurrent.com/trials/antigenic-competition-in-hiv-preventive-vaccines-129057https://curecurrent.com/trials/evaluating-the-safety-of-and-immune-response-to-the-vsv-indiana-hiv-vaccine-in-healthy-hiv-uninfected-adults-129058https://curecurrent.com/trials/evaluating-the-safety-tolerability-and-immunogenicity-of-a-prime-boost-regimen-of-hiv-1-nef-tat-vif-env-pdna-vaccine-del-129059https://curecurrent.com/trials/evaluating-the-safety-and-immune-response-to-an-hiv-vaccine-in-healthy-hiv-uninfected-adults-who-have-participated-in-pr-129060https://curecurrent.com/trials/safety-and-immune-response-study-of-the-vaccine-alvac-vcp1452-alone-or-in-combination-with-aidsvax-b-b-129061https://curecurrent.com/trials/evaluating-the-safety-and-immune-response-to-three-different-prime-boost-hiv-vaccine-regimens-in-healthy-hiv-uninfected-129062https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-pennvax-gp-dna-vaccine-and-il-12-plasmid-delivered-via-intradermal-or-intram-129063https://curecurrent.com/trials/evaluating-the-safety-and-immune-response-of-a-prime-boost-hiv-vaccine-regimen-in-healthy-hiv-uninfected-vaccinia-naive-129064https://curecurrent.com/trials/immunogenicity-of-covid-19-vaccination-in-plwh-129065https://curecurrent.com/trials/evaluating-the-immune-response-to-a-rad5-hiv-vaccine-administered-in-three-different-ways-in-healthy-hiv-uninfected-adul-129066https://curecurrent.com/trials/evaluating-the-safety-of-and-immune-response-to-hiv-mag-dna-vaccine-with-or-without-plasmid-il-12-adjuvant-delivered-int-129067https://curecurrent.com/trials/hvtn-protocol-204-a-phase-ii-clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-a-multiclade-hiv-1-dna-plasmid-129068https://curecurrent.com/trials/evaluating-heterologous-insert-prime-boost-hiv-vaccine-regimens-in-hiv-uninfected-adults-129069https://curecurrent.com/trials/early-immune-responses-to-vaccination-a-substudy-to-hvtn-205-129070https://curecurrent.com/trials/examining-the-role-of-genetics-in-determining-the-immune-response-to-an-hiv-vaccine-in-hiv-uninfected-adult-twins-129071https://curecurrent.com/trials/safety-and-efficacy-of-a-three-dose-regimen-of-an-adenoviral-hiv-vaccine-mrkad5-hiv-1-gag-pol-nef-in-hiv-uninfected-sout-129072https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-the-ihv01-protein-vaccine-primed-and-co-administered-with-hiv-dna-con-s-env-129073https://curecurrent.com/trials/evaluating-the-safety-and-immune-response-to-three-hiv-vaccine-schedules-in-healthy-hiv-uninfected-adults-129074https://curecurrent.com/trials/safety-of-and-immune-system-response-to-an-hiv-vaccine-ep-hiv-1090-in-hiv-uninfected-adults-129075https://curecurrent.com/trials/safety-of-and-immune-response-to-a-dna-vaccine-and-a-recombinant-hiv-1-mva-vaccine-separately-and-in-combination-in-heal-129076https://curecurrent.com/trials/immune-response-to-an-hiv-dna-plasmid-vaccine-prime-followed-by-adenovirus-boost-in-hiv-uninfected-individuals-129077https://curecurrent.com/trials/alvac-hiv-vcp1452-alone-and-combined-with-mn-rgp120-129078https://curecurrent.com/trials/safety-of-and-immune-response-to-an-hiv-1-vaccine-boost-vrc-hivadv014-00-vp-in-hiv-uninfected-adults-who-participated-in-129079https://curecurrent.com/trials/safety-of-an-hiv-dna-vaccine-given-to-hiv-uninfected-adults-129080https://curecurrent.com/trials/safety-and-immune-response-study-of-high-dose-canarypox-alvac-hiv-vaccine-in-healthy-hiv-uninfected-adults-129081https://curecurrent.com/trials/a-study-of-lipo-5-and-alvac-hiv-vcp1452-as-possible-hiv-vaccines-129082https://curecurrent.com/trials/improving-south-african-government-workers-capacities-to-deliver-hiv-interventions-129083https://curecurrent.com/trials/safety-and-immune-response-to-preventive-hiv-immunization-with-adenovirus-serotype-5-or-35-vector-129084https://curecurrent.com/trials/safety-of-and-immune-response-to-two-hiv-vaccine-formulations-rmva-hiv-and-rfpv-hiv-alone-or-in-combination-in-hiv-uninf-129085https://curecurrent.com/trials/safety-of-and-immune-response-to-an-hiv-preventive-vaccine-hiv-1-gag-dna-alone-or-with-il-15-dna-given-with-or-without-2-129086https://curecurrent.com/trials/safety-of-and-immune-response-to-an-hiv-1-dna-vaccine-vrc-hivdna009-00-vp-in-hiv-uninfected-adults-129087https://curecurrent.com/trials/safety-of-and-immune-response-to-a-new-hiv-vaccine-hiv-ctl-mep-129088https://curecurrent.com/trials/safety-of-and-immune-response-to-a-dna-hiv-vaccine-followed-by-boosting-with-one-of-two-serotypes-of-adenoviral-vector-h-129089https://curecurrent.com/trials/safety-of-and-immune-response-to-two-different-hiv-vaccines-each-followed-by-a-adenoviral-vaccine-boost-in-hiv-uninfecte-129090https://curecurrent.com/trials/neighborhood-alcohol-hiv-prevention-in-south-african-townships-philani-129091https://curecurrent.com/trials/evaluating-the-safety-and-immune-response-to-an-hiv-vaccine-boost-following-the-administration-of-two-hiv-vaccines-in-hi-129092https://curecurrent.com/trials/safety-of-and-immune-response-to-a-dna-hiv-vaccine-followed-by-an-adenoviral-vaccine-boost-given-three-different-ways-to-129093https://curecurrent.com/trials/safety-of-and-immune-response-to-an-hiv-vaccine-vrc-hivdna009-00-vp-administered-with-interleukin-2-immunoglobulin-il-2-129094https://curecurrent.com/trials/safety-of-and-immune-response-to-an-experimental-hiv-vaccine-vrc-hivadv014-00-vp-in-hiv-uninfected-adults-129095https://curecurrent.com/trials/study-of-an-hiv-preventive-vaccine-given-with-or-without-an-adjuvant-in-hiv-uninfected-adults-129096https://curecurrent.com/trials/safety-of-and-immune-response-to-the-experimental-preventive-hiv-vaccine-ep-hiv-1090-in-healthy-hiv-1-uninfected-adults-129097https://curecurrent.com/trials/an-investigational-combination-vaccine-given-to-people-who-are-not-infected-with-hiv-129098https://curecurrent.com/trials/safety-and-effectiveness-of-pennvax-b-vaccine-alone-with-il-12-or-il-15-in-healthy-adults-129099https://curecurrent.com/trials/safety-of-and-immune-response-to-two-hiv-vaccines-saavi-dna-c2-boosted-with-saavimva-c-in-hiv-negative-adults-129100https://curecurrent.com/trials/expanded-characterization-of-immune-response-to-merck-adenovirus-5-gag-pol-nef-vaccine-given-to-hiv-uninfected-adults-129101https://curecurrent.com/trials/safety-of-and-immune-response-to-the-pennvax-b-dna-vaccine-with-and-without-il-12-in-hiv-uninfected-adults-129102https://curecurrent.com/trials/safety-of-and-immune-response-to-a-combination-hiv-vaccine-regimen-in-hiv-uninfected-adults-129103https://curecurrent.com/trials/gardasil-immunogenicity-with-needle-free-injection-129104https://curecurrent.com/trials/longitudinal-pediatric-palliative-care-quality-of-life-spiritual-struggle-129105https://curecurrent.com/trials/combination-therapy-with-vrc01-and-10-1074-in-hiv-infected-individuals-undergoing-sequential-treatment-interruptions-129106https://curecurrent.com/trials/scalable-interventions-to-increase-prep-adherence-value-affirmation-and-future-selves-129107https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-an-hiv-vaccine-gp145-c-6980-in-healthy-hiv-uninfected-adults-in-the-united-s-129108https://curecurrent.com/trials/optimised-electronic-patient-records-to-improve-clinical-monitoring-of-hiv-positive-patients-in-rural-south-africa-129109https://curecurrent.com/trials/leveraging-family-based-assets-for-black-msm-in-house-ball-communities-129110https://curecurrent.com/trials/provision-of-hiv-self-test-kit-to-emergency-department-patients-129111https://curecurrent.com/trials/hiv-sequencing-after-treatment-interruption-to-identify-the-clinically-relevant-anatomical-reservoir-129112https://curecurrent.com/trials/patch-study-intervention-for-hiv-positive-smokers-129113https://curecurrent.com/trials/test-albuvirtide-in-experienced-patients-129114https://curecurrent.com/trials/a-safety-and-tolerability-study-of-nitazoxanide-in-hiv-hcv-treatment-failures-129115https://curecurrent.com/trials/online-network-intervention-to-increase-hiv-pre-exposure-prophylaxis-intention-129116https://curecurrent.com/trials/strategies-to-reduce-mortality-among-hiv-infected-and-hiv-exposed-children-admitted-with-severe-acute-malnutrition-129117https://curecurrent.com/trials/validation-of-a-urine-assay-to-measure-tenofovir-levels-in-patients-taking-tenofovir-alafenamide-129118https://curecurrent.com/trials/creating-a-virtual-village-for-people-aging-with-hiv-during-covid-19-129119https://curecurrent.com/trials/youth-engagement-study-intervention-to-increase-hiv-treatment-engagement-and-adherence-for-young-people-living-with-hiv-129120https://curecurrent.com/trials/texting-intervention-to-sustain-hiv-prevention-in-women-in-high-drug-use-contexts-129121https://curecurrent.com/trials/contingency-management-for-prep-adherence-and-or-methamphetamine-use-129122https://curecurrent.com/trials/albuvirtide-in-combination-with-3bnc117-in-patients-with-multi-drug-resistant-mdr-hiv-1-infection-129123https://curecurrent.com/trials/safety-study-of-fluconazole-in-combination-with-flucytosine-for-the-treatment-of-early-cryptococcal-infection-129124https://curecurrent.com/trials/understanding-barriers-and-facilitators-to-the-participation-of-women-living-with-hiv-in-clinical-trials-a-mixed-method-129125https://curecurrent.com/trials/linezolid-aspirin-and-enhanced-dose-rifampicin-in-hiv-tbm-129126https://curecurrent.com/trials/therapy-to-elevate-cd4-counts-in-hiv-1-disease-129127https://curecurrent.com/trials/mamas-mentoring-adolescent-mothers-at-school-129128https://curecurrent.com/trials/viral-dynamics-and-pharmacokinetics-of-abacavir-and-tenofovir-129129https://curecurrent.com/trials/interventions-to-improve-hiv-antiretroviral-therapy-adherence-129130https://curecurrent.com/trials/low-dose-fostemsavir-extended-release-relative-bioavailability-study-129131https://curecurrent.com/trials/prep-in-breastfeeding-study-129132https://curecurrent.com/trials/collecting-and-storing-blood-samples-from-patients-with-cancer-129133https://curecurrent.com/trials/a-study-of-the-pharmacokinetic-and-pharmacodynamic-interactions-between-bictegravir-tenofovir-alafenamide-and-rifapentin-129134https://curecurrent.com/trials/test-work-study-evaluation-of-attitudes-and-uptake-within-employee-health-checks-in-the-construction-industry-129135https://curecurrent.com/trials/information-visualizations-to-facilitate-hiv-related-patient-provider-communication-in-new-york-city-info-viz-hiv-nyc-129136https://curecurrent.com/trials/safety-and-immune-response-of-covid-19-vaccination-in-patients-with-hiv-infection-129137https://curecurrent.com/trials/acceptability-feasibility-and-preliminary-impact-of-ourplan-an-mhealth-hiv-prevention-intervention-for-male-couples-129138https://curecurrent.com/trials/stable-iron-isotope-method-in-hiv-and-hiv-children-129139https://curecurrent.com/trials/young-men-and-media-study-129140https://curecurrent.com/trials/a-cost-effective-and-time-saving-blood-test-to-detect-six-human-bloodborne-infectious-diseases-129141https://curecurrent.com/trials/linkage-of-transgender-individuals-to-prep-129142https://curecurrent.com/trials/the-bridges-project-bridging-resources-to-engage-women-in-integrated-hiv-care-and-support-services-129143https://curecurrent.com/trials/randomized-controlled-trial-of-itab-plus-motivational-interviewing-for-prep-adherence-in-transgender-individuals-129144https://curecurrent.com/trials/a-habit-formation-and-gamification-intervention-to-improve-art-adherence-among-msm-hiv-patients-in-mexico-129145https://curecurrent.com/trials/diagnostic-performance-of-a-novel-lipoarabinomannan-129146https://curecurrent.com/trials/control-and-elimination-within-australia-of-hepatitis-c-from-people-living-with-hiv-129147https://curecurrent.com/trials/hiv-and-inflammatory-or-autoimmune-disease-rare-patients-many-questions-maivih-129148https://curecurrent.com/trials/evaluation-of-safety-and-dosing-of-a-vitamin-c-bundle-for-sepsis-treatment-in-africa-129149https://curecurrent.com/trials/impact-of-daa-uptake-in-controlling-hcv-epidemic-and-modeling-interventions-for-hcv-elimination-among-hiv-infected-perso-129150https://curecurrent.com/trials/effect-on-liver-fat-and-metabolic-parameters-when-switching-a-protease-inhibitor-or-efavirenz-to-raltegravir-129151https://curecurrent.com/trials/mobile-health-interventions-for-medication-adherence-among-plwh-129152https://curecurrent.com/trials/effects-of-health-literacy-and-hcv-knowledge-on-hcv-treatment-willingness-in-hiv-coinfected-patients-129153https://curecurrent.com/trials/stigma-risk-behaviors-and-health-care-among-hiv-infected-russian-people-who-inject-drugs-129154https://curecurrent.com/trials/regional-differences-in-human-immunodeficiency-virus-hiv-testing-129155https://curecurrent.com/trials/the-people-like-us-evaluation-study-129156https://curecurrent.com/trials/adherence-hiv-1-infection-resistance-and-renal-and-skeletal-adverse-event-in-individuals-taking-truvada-for-hiv-pre-expo-129157https://curecurrent.com/trials/efficacy-and-safety-of-a-dolutegravir-based-regimen-for-the-initial-management-of-hiv-infected-adults-in-resource-limite-129158https://curecurrent.com/trials/developing-a-prep-adherence-intervention-targeting-at-risk-and-substance-using-women-129159https://curecurrent.com/trials/tripe-versus-dual-antiretroviral-therapy-in-hiv-infected-patients-with-virological-suppression-tridual-129160https://curecurrent.com/trials/maraviroc-and-neuroaids-pathogenesis-129161https://curecurrent.com/trials/ise-sant-a-study-evaluating-a-model-for-implementing-e-health-in-the-management-of-hiv-patients-129162https://curecurrent.com/trials/texting-to-improve-adherence-in-hiv-with-bipolar-disorder-129163https://curecurrent.com/trials/social-capital-and-engagement-in-care-among-young-black-men-who-have-sex-with-men-living-with-hiv-129164https://curecurrent.com/trials/personalized-text-messages-to-improve-antiretroviral-treatment-art-adherence-in-hiv-methamphetamine-users-129165https://curecurrent.com/trials/evaluation-of-third-line-cart-regimen-in-cambodia-3dicam-129166https://curecurrent.com/trials/pilot-study-of-a-transition-intervention-for-alwh-129167https://curecurrent.com/trials/mi-based-prep-intervention-129168https://curecurrent.com/trials/drug-drug-interactions-between-remdesivir-and-commonly-used-antiretroviral-therapy-129169https://curecurrent.com/trials/development-and-pilot-testing-of-a-phci-for-emergency-department-patients-who-decline-rapid-hiv-hcv-screening-129170https://curecurrent.com/trials/couples-health-project-couples-based-intervention-to-reduce-drug-use-and-hiv-transmission-risk-129171https://curecurrent.com/trials/assessing-the-feasibility-acceptability-and-effects-of-hiv-birth-testing-in-maternity-settings-in-zimbabwe-129172https://curecurrent.com/trials/does-preference-based-hiv-testing-increase-uptake-in-high-risk-populations-129173https://curecurrent.com/trials/healthcall-brief-intervention-to-reduce-non-injecting-drug-use-in-hiv-primary-care-clinics-129174https://curecurrent.com/trials/healthcall-s-a-pilot-study-targeting-concurrent-non-injection-drug-use-and-alcohol-in-hiv-primary-care-clinics-129175https://curecurrent.com/trials/the-healthy-life-choices-project-in-hiv-positive-patients-129176https://curecurrent.com/trials/hiv-fat-redistribution-and-the-evaluation-of-brown-fat-129177https://curecurrent.com/trials/hepatic-safety-of-raltegravir-versus-efavirenz-as-hiv-therapy-for-patients-with-hiv-and-hcv-coinfection-129178https://curecurrent.com/trials/body-compartment-pharmacokinetics-of-anti-retroviral-agents-that-may-be-considered-for-future-on-demand-peri-exposure-hi-129179https://curecurrent.com/trials/impaact-p1092-steady-state-pk-in-malnourished-hiv-infected-children-129180https://curecurrent.com/trials/direct-and-spillover-impacts-of-a-community-level-hiv-aids-program-129181https://curecurrent.com/trials/dose-safety-tolerability-and-immunogenicity-of-an-hiv-1-vaccine-vrc-hivrgp096-00-vp-with-alum-in-healthy-adults-129182https://curecurrent.com/trials/altering-mechanisms-of-frailty-in-persons-living-with-hiv-aged-50-to-65-129183https://curecurrent.com/trials/effects-of-sofosbuvir-ledipasvir-treatment-on-the-pharmacokinetics-and-renal-safety-of-tenofovir-129184https://curecurrent.com/trials/covid-19-prevalence-in-hiv-infected-patients-129185https://curecurrent.com/trials/evaluation-of-a-tailored-virtual-intervention-to-empower-persons-living-with-hiv-for-therapy-self-management-129186https://curecurrent.com/trials/impaact-p1106-pharmacokinetic-characteristics-of-antiretrovirals-and-tuberculosis-medicines-in-low-birth-weight-infants-129187https://curecurrent.com/trials/the-effects-of-a-mobile-application-based-physical-activity-intervention-in-plwh-129188https://curecurrent.com/trials/cups-or-cash-for-girls-trial-to-reduce-sexual-and-reproductive-harm-and-school-dropout-129189https://curecurrent.com/trials/first-in-human-study-of-10-1074-ls-alone-and-in-combination-with-3bnc117-ls-129190https://curecurrent.com/trials/adapting-an-evidence-based-intervention-for-stigma-related-stress-mental-health-and-hiv-risk-for-msm-of-color-in-small-u-129191https://curecurrent.com/trials/plus-pink-hhrp-adaptation-for-women-with-hiv-under-community-supervision-129192https://curecurrent.com/trials/telmisartan-to-reduce-aids-related-fibrotic-and-inflammatory-contributors-trafic-study-129193https://curecurrent.com/trials/safety-and-efficacy-of-sirolimus-for-hiv-reservoir-reduction-in-individuals-on-suppressive-antiretroviral-therapy-art-129194https://curecurrent.com/trials/impaact-p1080-psychiatric-and-antiretroviral-medication-concentrations-in-hiv-infected-and-uninfected-children-and-adole-129195https://curecurrent.com/trials/a-one-stop-shop-for-the-same-day-diagnosis-and-management-of-tb-and-hiv-129196https://curecurrent.com/trials/impact-of-long-term-protease-inhibitors-in-patients-living-with-hiv-on-the-incidence-of-covid-19-covip-129197https://curecurrent.com/trials/peri-implantitis-in-hiv-positive-patients-with-different-dental-prosthesis-129198https://curecurrent.com/trials/care4today-v2-0-application-for-improving-adherence-to-hiv-medications-129199https://curecurrent.com/trials/the-impact-of-helicobacter-pylori-infection-on-immune-regulation-and-clinical-course-in-hiv-patients-in-ghana-129200https://curecurrent.com/trials/kumasi-cohort-study-129201https://curecurrent.com/trials/study-of-the-effects-of-farnesoid-x-receptor-fxr-ligands-on-the-reactivation-of-latent-provirus-129202https://curecurrent.com/trials/options-a-patient-centered-hiv-prevention-decision-aid-for-prep-uptake-for-women-with-substance-use-in-treatment-setting-129203https://curecurrent.com/trials/project-empowering-evidence-based-prep-for-justice-involved-women-and-their-risk-networks-129204https://curecurrent.com/trials/alcohol-and-immune-response-129205https://curecurrent.com/trials/empower-nudge-increasing-dual-protection-in-south-africa-129206https://curecurrent.com/trials/understanding-and-intervening-with-heavy-drinking-among-patients-with-hiv-and-hcv-129207https://curecurrent.com/trials/the-role-of-home-packs-of-hiv-pepse-in-high-risk-individuals-129208https://curecurrent.com/trials/deep-learning-based-system-and-aids-related-cytomegalovirus-retinitis-129209https://curecurrent.com/trials/combination-partner-hiv-testing-strategies-for-hiv-positive-and-hiv-negative-pregnant-women-129210https://curecurrent.com/trials/latent-hiv-1-viral-suppress-and-hope-for-hiv-cure-129211https://curecurrent.com/trials/effect-of-chidamide-combined-with-cat-t-or-tcr-t-cell-therapy-on-hiv-1-latent-reservoir-129212https://curecurrent.com/trials/bictegravir-ftc-taf-for-the-treatment-of-primary-hiv-infection-129213https://curecurrent.com/trials/start-tb-patients-on-art-and-retain-on-treatment-start-study-129214https://curecurrent.com/trials/enhance-initiation-and-retention-in-isoniazid-preventive-therapy-ipt-care-for-hiv-study-enrich-study-129215https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-experimental-drugs-abt-493-abt-530-in-adults-with-chronic-hepatitis-c-vir-129216https://curecurrent.com/trials/the-thai-red-cross-society-prevention-of-mother-to-child-transmission-of-hiv-trcs-pmtct-program-129217https://curecurrent.com/trials/nevirapine-clearance-after-short-term-highly-active-antiretroviral-therapy-haart-for-prevention-of-mother-to-child-trans-129218https://curecurrent.com/trials/a-multipart-open-label-study-to-evaluate-the-safety-and-efficacy-of-abt-450-r-abt-267-with-and-without-abt-333-coadminis-129219https://curecurrent.com/trials/darunavir-cobicistat-and-dolutegravir-to-maintain-virologic-suppression-and-reduce-nrti-associated-toxicity-129220https://curecurrent.com/trials/pre-exposure-prophylaxis-prep-adherence-enhancement-guided-by-itab-and-drug-levels-for-women-129221https://curecurrent.com/trials/testing-the-effect-of-raltegravir-on-persistent-de-novo-hiv-infection-in-virologic-responders-to-antiretroviral-therapy-129222https://curecurrent.com/trials/intranasal-insulin-for-the-treatment-of-hand-129223https://curecurrent.com/trials/a-study-to-assess-effectiveness-and-safety-of-fixed-dose-combination-of-lopinavir-ritonavir-lpv-r-in-human-immunodeficie-129224https://curecurrent.com/trials/study-to-assess-the-acceptability-of-darunavir-cobicistat-emtricitabine-tenofovir-alafenamide-d-c-f-taf-fixed-dose-combi-129225https://curecurrent.com/trials/smoking-cessation-for-people-living-with-hiv-aids-129226https://curecurrent.com/trials/90-days-an-entertainment-education-intervention-to-evaluate-a-short-film-about-hiv-status-disclosure-129227https://curecurrent.com/trials/tenofovir-levels-following-local-application-of-tenofovir-reduced-glycerin-1-gel-129228https://curecurrent.com/trials/peg-interferon-alpha-2b-combined-with-two-intravenous-broadly-hiv-1-neutralizing-antibodies-3bnc117-and-10-1074-beat-2-129229https://curecurrent.com/trials/financial-incentives-to-increase-pediatric-hiv-testing-129230https://curecurrent.com/trials/safety-and-acceptability-study-of-oral-emtricitabine-tenofovir-disoproxil-fumarate-tablet-and-rectally-applied-tenofovir-129231https://curecurrent.com/trials/developing-and-assessing-a-male-engagement-intervention-in-option-b-in-malawi-129232https://curecurrent.com/trials/hiv-persistence-in-lymph-node-and-peripheral-blood-129233https://curecurrent.com/trials/an-exploratory-study-of-potential-sources-of-efficacy-dilution-in-the-voice-trial-mtn-003-129234https://curecurrent.com/trials/cognitive-training-with-and-without-tdcs-to-improve-cognition-in-hiv-129235https://curecurrent.com/trials/hiv-1-resistance-at-screening-for-hiv-prevention-studies-129236https://curecurrent.com/trials/embrace-evaluation-of-maternal-and-baby-outcome-registry-after-chemoprophylactic-exposure-129237https://curecurrent.com/trials/hiv-results-exchange-mechanism-on-promoting-hiv-testing-among-msm-129238https://curecurrent.com/trials/observational-study-of-hiv-infected-women-previously-enrolled-in-other-microbicide-trials-129239https://curecurrent.com/trials/drug-counseling-and-abstinent-contingent-take-home-buprenorphine-in-malaysia-129240https://curecurrent.com/trials/vaginal-microbiota-and-sti-hiv-risk-among-adolescent-girls-and-young-women-129241https://curecurrent.com/trials/a-risky-sex-prevention-intervention-for-middle-school-age-minority-girls-129242https://curecurrent.com/trials/a-study-of-the-safety-and-antiretroviral-activity-of-3bnc117-129243https://curecurrent.com/trials/early-identification-and-treatment-of-early-hiv-infection-in-c-te-d-ivoire-129244https://curecurrent.com/trials/treating-comorbid-pain-and-depression-in-hiv-individuals-129245https://curecurrent.com/trials/gsk3640254-first-time-in-human-ftih-study-in-healthy-volunteers-129246https://curecurrent.com/trials/effectiveness-and-b-memory-cell-response-to-qhpv-vaccine-9-years-post-vaccination-among-hiv-infected-boys-and-girls-129247https://curecurrent.com/trials/pharmacokinetics-of-single-dose-dolutegravir-in-hiv-seronegative-subjects-with-severe-hepatic-impairment-compared-to-mat-129248https://curecurrent.com/trials/tenofovir-rectal-douche-to-prevent-hiv-transmission-129249https://curecurrent.com/trials/cohort-study-on-people-who-inject-drugs-in-senegal-129250https://curecurrent.com/trials/impact-of-physical-activity-and-diet-on-symptom-experience-in-people-living-with-hiv-129251https://curecurrent.com/trials/vicriviroc-sch-417690-in-combination-treatment-with-optimized-art-regimen-in-experienced-participants-victor-e1-mk-7690-129252https://curecurrent.com/trials/enhanced-adherence-counselling-pre-post-study-129253https://curecurrent.com/trials/speed-of-processing-training-in-adults-with-hiv-129254https://curecurrent.com/trials/a-prospective-observational-study-to-examine-the-effects-of-ageing-on-the-clinical-outcomes-of-people-living-with-hiv-in-129255https://curecurrent.com/trials/development-and-implementation-of-an-hiv-testing-intervention-for-primary-care-in-belgium-129256https://curecurrent.com/trials/peer-educator-coordinated-vs-nurse-coordinated-art-refill-for-adolescents-and-young-adults-living-with-hiv-in-lesotho-129257https://curecurrent.com/trials/periconception-prep-for-hiv-exposed-ugandan-women-129258https://curecurrent.com/trials/dose-escalation-study-of-cyclophosphamide-in-hiv-infected-subjects-on-haart-receiving-sb-728-t-129259https://curecurrent.com/trials/gsk1265744-cabotegravir-cab-for-named-patient-compassionate-use-in-hiv-129260https://curecurrent.com/trials/wemen-improving-women-s-access-to-healthcare-system-through-men-s-inclusion-129261https://curecurrent.com/trials/high-risk-crack-use-settings-and-hiv-in-el-salvador-129262https://curecurrent.com/trials/mobile-augmented-screening-tool-to-increase-adolescent-hiv-testing-and-linkage-to-care-129263https://curecurrent.com/trials/a-safety-tolerability-acceptability-and-pharmacokinetic-pk-study-of-cabotegravir-cab-in-healthy-human-immunodeficiency-v-129264https://curecurrent.com/trials/cctg-593-testing-and-linkage-to-care-129265https://curecurrent.com/trials/study-of-truvada-for-hiv-pre-exposure-prophylaxis-using-daily-directly-observed-therapy-to-look-at-potential-interaction-129266https://curecurrent.com/trials/telephone-based-cognitive-behavioral-therapy-for-hiv-related-depression-129267https://curecurrent.com/trials/a-study-to-evaluate-of-the-efficacy-of-enfuvirtide-during-the-induction-phase-of-therapy-129268https://curecurrent.com/trials/lynx-a-novel-mobile-app-to-support-linkage-to-hiv-sti-testing-prep-for-young-men-who-have-sex-with-men-129269https://curecurrent.com/trials/safety-and-durability-oftenofovir-and-a-cell-cycle-agent-for-viral-suppression-129270https://curecurrent.com/trials/could-dietary-algae-affect-immunity-and-viral-counts-in-people-with-hiv-129271https://curecurrent.com/trials/introduction-study-of-dual-hiv-syphilis-rapid-diagnostic-tests-in-antenatal-clinics-in-colombia-129272https://curecurrent.com/trials/phase-1-pilot-study-of-an-art-bridging-regimen-in-highly-experienced-patients-unable-to-achieve-viral-suppression-129273https://curecurrent.com/trials/assessment-of-a-new-boosting-strategy-for-hiv-pre-exposure-prophylaxis-in-healthy-volunteers-129274https://curecurrent.com/trials/the-medicines-optimisation-review-toolkit-evaluation-in-hiv-outpatients-129275https://curecurrent.com/trials/a-trial-to-compare-antibacterial-vs-placebo-mouthwash-to-reduce-the-incidence-of-sexually-transmitted-infections-stis-in-129276https://curecurrent.com/trials/relaxation-depressive-symptoms-quality-of-life-in-people-living-with-hiv-a-pilot-study-129277https://curecurrent.com/trials/cardiometabolic-health-of-children-exposed-to-anti-retroviral-therapy-art-in-utero-129278https://curecurrent.com/trials/safety-and-immunogenicity-following-meningococcal-and-pneumococcal-immunization-among-adult-people-living-with-hiv-129279https://curecurrent.com/trials/randomized-controlled-trial-of-trauma-focused-cbt-in-tanzania-and-kenya-129280https://curecurrent.com/trials/art-chess-a-mobile-health-application-to-support-people-living-with-hiv-and-addiction-129281https://curecurrent.com/trials/peer-delivered-hiv-self-testing-sti-self-sampling-and-prep-for-transgender-women-in-uganda-129282https://curecurrent.com/trials/anrs-12406-evva-study-129283https://curecurrent.com/trials/national-cohort-of-children-born-to-hiv-positive-mothers-129284https://curecurrent.com/trials/patient-reported-outcomes-hiv-bitherapy-129285https://curecurrent.com/trials/using-smart-phone-technology-to-support-prep-uptake-and-adherence-129286https://curecurrent.com/trials/rice-bran-supplementation-in-treated-hiv-infection-129287https://curecurrent.com/trials/lras-united-as-a-novel-anti-hiv-strategy-129288https://curecurrent.com/trials/enhancing-linkage-to-hiv-care-for-newly-detected-hiv-positive-persons-in-ukraine-129289https://curecurrent.com/trials/third-generation-car-t-cell-therapy-in-individuals-with-hiv-1-infection-129290https://curecurrent.com/trials/international-validation-of-a-sexual-quality-of-life-questionnaire-specific-to-hiv-and-hepatitis-c-proqol-sexlife-129291https://curecurrent.com/trials/impact-of-hepatitis-c-virus-therapy-on-central-nervous-system-outcomes-129292https://curecurrent.com/trials/effects-of-an-hiv-intervention-among-sex-workers-in-the-philippines-129293https://curecurrent.com/trials/mother-and-infant-visit-adherence-and-treatment-engagement-study-129294https://curecurrent.com/trials/prospective-cohort-study-of-adolescents-living-with-hiv-and-their-caregivers-attending-a-psychosocial-programme-in-botsw-129295https://curecurrent.com/trials/comparative-pharmacokinetics-pk-study-of-efavirenz-or-lopinavir-ritonavir-between-older-and-younger-hiv-infected-adults-129296https://curecurrent.com/trials/effect-of-berberine-on-metabolic-syndrome-efficacy-and-safety-in-combination-with-antiretroviral-therapy-in-plwh-129297https://curecurrent.com/trials/adoptive-transfer-of-haploidentical-nk-cells-and-n-803-129298https://curecurrent.com/trials/innovative-approaches-for-minor-consent-consent-2-0-129299https://curecurrent.com/trials/effect-of-high-dose-vitamin-d3-in-smokers-and-non-smokers-with-and-without-hiv-129300https://curecurrent.com/trials/the-stay-study-a-demonstration-project-advancing-prep-delivery-in-the-san-francisco-bay-area-transgender-community-129301https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-vesatolimod-in-antiretroviral-treated-human-immunodeficiency-virus-hiv-1-in-129302https://curecurrent.com/trials/family-planning-and-hiv-in-postpartum-women-in-mbarara-129303https://curecurrent.com/trials/addressing-substance-use-through-cvct-129304https://curecurrent.com/trials/acceptability-and-feasibility-in-the-context-of-the-improve-trial-in-kenya-129305https://curecurrent.com/trials/prevention-of-malaria-in-hiv-uninfected-pregnant-women-and-infants-129306https://curecurrent.com/trials/cohort-of-hiv-infected-children-129307https://curecurrent.com/trials/prospective-observational-cohort-study-on-mother-to-child-transmission-hiv1-hiv2-and-prevention-129308https://curecurrent.com/trials/study-to-evaluate-switching-from-a-tdf-containing-combination-regimen-to-a-taf-containing-fixed-dose-combination-fdc-in-129309https://curecurrent.com/trials/improving-hiv-and-alcohol-related-outcomes-among-hiv-persons-in-clinic-settings-129310https://curecurrent.com/trials/immediate-fast-track-versus-standard-care-for-persons-living-with-hiv-in-haiti-129311https://curecurrent.com/trials/study-to-evaluate-safety-pharmacokinetics-and-antiviral-activity-of-lenacapavir-administered-subcutaneously-in-human-imm-129312https://curecurrent.com/trials/home-study-a-combination-support-package-to-increase-uptake-of-prep-and-hiv-sti-testing-129313https://curecurrent.com/trials/telephone-counseling-to-enhance-the-quality-and-safety-of-romantic-and-sexual-relationships-in-people-living-and-aging-w-129314https://curecurrent.com/trials/the-tailored-motivational-interviewing-project-129315https://curecurrent.com/trials/safety-and-immunogenicity-study-of-dna-hti-mva-hti-and-chadox1-hti-in-hiv-1-positive-patients-aelix-002-129316https://curecurrent.com/trials/pre-approval-access-to-rilpivirine-long-acting-rpv-la-injectable-suspension-for-the-treatment-of-a-participant-with-huma-129317https://curecurrent.com/trials/peri-implantitis-in-hiv-positive-patients-129318https://curecurrent.com/trials/reaching-90-hiv-suppression-the-role-of-poc-viral-load-monitoring-in-nigeria-129319https://curecurrent.com/trials/village-based-vs-clinic-based-art-care-a-cluster-randomized-controlled-trial-in-lesotho-129320https://curecurrent.com/trials/rapid-hiv-viral-load-monitoring-in-high-risk-patients-in-uganda-129321https://curecurrent.com/trials/strategy-for-maintenance-of-hiv-suppression-with-once-daily-integrate-inhibitor-darunavir-ritonavir-in-children-129322https://curecurrent.com/trials/project-jumpstart-for-improving-prep-care-of-continuum-outcomes-129323https://curecurrent.com/trials/stigma-and-online-counseling-to-increase-hiv-sti-testing-129324https://curecurrent.com/trials/increasing-prep-among-african-americans-in-louisville-ky-129325https://curecurrent.com/trials/lipoarabinomannan-lam-in-urine-for-diagnosis-of-pulmonary-tuberculosis-in-hiv-patients-129326https://curecurrent.com/trials/albuvirtide-in-combination-with-3bnc117-in-virologically-suppressed-subjects-with-hiv-1-infection-129327https://curecurrent.com/trials/study-of-boosting-strategies-after-vaccination-with-alvac-hiv-and-aidsvax-b-e-129328https://curecurrent.com/trials/cross-sectional-cfar-hiv-covid-19-study-129329https://curecurrent.com/trials/clinical-phenotyping-and-genotyping-of-hiv-associated-sensory-neuropathy-the-hiv-pogo-study-129330https://curecurrent.com/trials/evaluating-the-impact-of-incentives-on-clinical-trial-participation-129331https://curecurrent.com/trials/repeat-doses-of-sb-728mr-t-after-cyclophosphamide-conditioning-in-hiv-infected-subjects-on-haart-129332https://curecurrent.com/trials/ob-002h-gel-administered-vaginally-and-rectally-in-hiv-1-seronegative-adults-129333https://curecurrent.com/trials/switch-from-nevirapine-based-regimen-to-once-a-day-rilpivirine-emtricitabine-tenofovir-129334https://curecurrent.com/trials/stanford-universities-the-stanford-hiv-aging-cohort-129335https://curecurrent.com/trials/drug-interaction-potential-between-dolutegravir-and-simeprevir-in-hiv-hcv-seronegative-volunteers-129336https://curecurrent.com/trials/time-to-protection-and-adherence-requirements-of-raltegravir-with-or-without-lamivudine-in-protection-from-hiv-infection-129337https://curecurrent.com/trials/an-adaptive-strategy-for-preventing-and-treating-lapses-of-retention-in-adult-hiv-care-adapt-r-in-nyanza-kenya-129338https://curecurrent.com/trials/effect-of-reducing-nucleotide-exposure-on-bone-health-renew-129339https://curecurrent.com/trials/bioequivalence-of-crushed-stribild-with-a-normal-breakfast-or-with-drip-feed-compared-to-the-whole-tablet-129340https://curecurrent.com/trials/risk-factors-for-non-hiv-related-kaposi-s-sarcoma-129341https://curecurrent.com/trials/option-b-study-on-safety-viral-suppression-and-survival-on-second-line-art-129342https://curecurrent.com/trials/ibalizumab-plus-optimized-background-regimen-in-treatment-experienced-patients-with-multi-drug-resistant-hiv-1-129343https://curecurrent.com/trials/triggered-escalating-real-time-adherence-tera-intervention-129344https://curecurrent.com/trials/brief-hiv-prevention-counseling-for-sti-patients-in-south-africa-129345https://curecurrent.com/trials/reduce-stigma-and-improve-treatment-adherence-in-hiv-pregnant-women-129346https://curecurrent.com/trials/pre-exposure-prophylaxis-prep-for-people-who-inject-drugs-pwid-129347https://curecurrent.com/trials/hpv-human-papilloma-virus-vaccination-after-treatment-of-anal-intraepithelial-neoplasia-ain-129348https://curecurrent.com/trials/efficacy-of-a-cognitive-behavioral-therapy-to-decrease-threat-appraisal-in-hiv-participants-initiating-antiretroviral-129349https://curecurrent.com/trials/the-effects-of-genetic-differences-among-aids-patients-on-cytomegalovirus-retinitis-129350https://curecurrent.com/trials/effects-of-maraviroc-mvc-on-hiv-related-kaposi-s-sarcoma-ks-129351https://curecurrent.com/trials/a-trial-with-tmc278-tidp6-c222-for-continued-tmc278-access-in-patients-infected-with-human-immunodeficiency-virus-1-129352https://curecurrent.com/trials/expanding-hiv-testing-among-uganda-adults-who-utilize-traditional-healers-129353https://curecurrent.com/trials/drug-use-and-infections-in-hai-phong-vietnam-among-persons-who-inject-drugs-129354https://curecurrent.com/trials/evaluation-of-the-shangring-vs-mogen-clamp-for-early-infant-male-circumcision-eimc-in-sub-saharan-africa-129355https://curecurrent.com/trials/impaact-2002-cognitive-behavioral-therapy-and-medication-management-for-treatment-of-depression-in-us-youth-with-hiv-129356https://curecurrent.com/trials/association-between-human-immunodeficiency-virus-hiv-infection-and-male-hypogonadism-129357https://curecurrent.com/trials/a-relative-bioavailability-and-food-effect-study-of-gsk3640254-tablet-and-capsule-formulations-in-healthy-participants-129358https://curecurrent.com/trials/natural-history-of-liver-cirrhosis-diagnosed-by-transient-elastography-in-hiv-hcv-coinfected-patients-129359https://curecurrent.com/trials/application-of-iv-99mtc-tilmanocept-for-imaging-of-macrophage-specific-inflammation-129360https://curecurrent.com/trials/testing-of-a-navigation-intervention-for-hepatitis-c-and-hiv-129361https://curecurrent.com/trials/hcv-reinfection-in-in-hiv-hcv-coinfected-patients-achieving-svr-by-antiviral-therapy-129362https://curecurrent.com/trials/tb-reduction-through-art-and-tb-screening-project-129363https://curecurrent.com/trials/anrs-12392-sanu-gundo-129364https://curecurrent.com/trials/male-partner-assisted-contact-tracing-for-hiv-and-tuberculosis-in-malawi-129365https://curecurrent.com/trials/defining-the-prep-care-continuum-among-recently-incarcerated-men-at-high-risk-for-hiv-infection-129366https://curecurrent.com/trials/simplified-monitoring-myanmar-sm2-study-129367https://curecurrent.com/trials/cognitive-behavioral-therapy-to-treat-insomnia-in-persons-with-hiv-infection-129368https://curecurrent.com/trials/cooperative-re-engagement-controlled-trial-corect-129369https://curecurrent.com/trials/glutathione-and-function-in-hiv-patients-129370https://curecurrent.com/trials/a-mobile-intervention-to-improve-uptake-of-prep-for-southern-black-msm-129371https://curecurrent.com/trials/evaluation-of-hiv-1-hcv-and-hbv-blood-screening-tests-with-human-blood-donor-specimens-129372https://curecurrent.com/trials/effect-of-zinc-supplementation-on-response-to-oral-polio-vaccine-in-infants-in-pakistan-129373https://curecurrent.com/trials/assessment-of-group-peer-support-to-children-with-hiv-in-vietnam-129374https://curecurrent.com/trials/safety-efficacy-and-pharmacokinetics-of-amphotericin-b-lipid-complex-129375https://curecurrent.com/trials/expanded-prep-implementation-in-communities-in-nsw-129376https://curecurrent.com/trials/counseling-and-reminders-for-regular-hiv-and-stis-screening-129377https://curecurrent.com/trials/a-proof-of-concept-study-of-gsk3640254-in-human-immunodeficiency-virus-1-hiv-1-infected-treatment-naive-adults-129378https://curecurrent.com/trials/improving-outcomes-in-hiv-patients-using-mobile-phone-based-interactive-software-support-129379https://curecurrent.com/trials/lafiyan-jikin-mata-excellent-health-for-mothers-129380https://curecurrent.com/trials/a-clinical-trial-comparing-the-efficacy-of-tenofovir-disoproxil-fumarate-emtricitabine-rilpivirine-tdf-ftc-rpv-versus-td-129381https://curecurrent.com/trials/effects-of-ledipasvir-sofosbuvir-on-the-pharmacokinetics-and-renal-safety-of-tenofovir-alafenamide-taf-129382https://curecurrent.com/trials/bangkok-tenofovir-study-an-hiv-pre-exposure-prophylaxis-trial-bangkok-thailand-129383https://curecurrent.com/trials/pregabalin-treatment-of-peripheral-neuropathic-pain-associated-with-diabetic-peripheral-nep-dpn-postherpetic-neuralgia-p-129384https://curecurrent.com/trials/study-of-pregabalin-versus-placebo-in-the-treatment-of-nerve-pain-associated-with-hiv-neuropathy-129385https://curecurrent.com/trials/gonadal-function-in-young-to-middle-aged-hiv-infected-men-129386https://curecurrent.com/trials/addressing-the-cascade-of-care-in-vulnerable-populations-with-poor-access-to-healthcare-in-madrid-129387https://curecurrent.com/trials/supporting-attendance-for-facility-delivery-and-infant-health-129388https://curecurrent.com/trials/elizabeth-glaser-pediatric-aids-foundation-maternal-events-and-pregnancy-outcomes-mep-project-a-multi-site-protocol-129389https://curecurrent.com/trials/role-of-pla2g1b-during-hiv-infection-129390https://curecurrent.com/trials/community-based-peer-facilitator-intervention-zimbabwe-129391https://curecurrent.com/trials/advancing-community-level-action-for-improving-mch-pmtct-129392https://curecurrent.com/trials/an-efficacy-and-safety-study-of-grazoprevir-mk-5172-elbasvir-mk-8742-in-the-treatment-of-chronic-hepatitis-c-virus-in-pa-129393https://curecurrent.com/trials/evaluating-the-feasibility-of-point-of-care-birth-testing-in-eswatini-129394https://curecurrent.com/trials/evaluation-of-innovative-combinatorial-strat-gies-of-anti-latency-and-anti-immune-activation-drugs-targeting-hiv-reservo-129395https://curecurrent.com/trials/impact-of-point-of-care-eid-for-hiv-exposed-infants-129396https://curecurrent.com/trials/cognitive-therapy-in-patients-failing-art-129397https://curecurrent.com/trials/impact-of-an-enhanced-screening-program-on-the-detection-of-non-aids-neoplasms-in-hiv-patients-129398https://curecurrent.com/trials/effect-of-social-media-support-and-financial-incentives-on-prep-adherence-129399https://curecurrent.com/trials/three-induction-treatments-on-cryptococcal-meningitis-129400https://curecurrent.com/trials/sofosbuvir-based-daa-therapy-in-hiv-hcv-coinfected-pre-or-post-liver-transplant-129401https://curecurrent.com/trials/scaling-up-tb-and-hiv-treatment-integration-129402https://curecurrent.com/trials/hiv-switch-trial-in-experienced-patients-with-multiple-class-resistance-including-nnrti-resistance-129403https://curecurrent.com/trials/pregabalin-trial-in-hiv-neuropathic-pain-129404https://curecurrent.com/trials/pregabalin-versus-placebo-in-the-treatment-of-neuropathic-pain-associated-with-hiv-neuropathy-129405https://curecurrent.com/trials/hiv-prevention-intervention-for-young-transgender-women-129406https://curecurrent.com/trials/hiv-prevention-among-vulnerable-male-youth-129407https://curecurrent.com/trials/testing-of-insti-hiv-1-antibody-test-kit-in-volunteer-subjects-at-risk-for-hiv-infection-129408https://curecurrent.com/trials/impact-of-point-of-care-poc-viral-load-vl-testing-during-pregnancy-in-zimbabwe-129409https://curecurrent.com/trials/influenza-vaccination-in-patients-living-with-hiv-in-the-northern-region-129410https://curecurrent.com/trials/open-label-safety-and-efficacy-study-of-pregabalin-in-subjects-with-nerve-pain-asociated-with-human-immunodeficiency-vir-129411https://curecurrent.com/trials/immunology-of-hiv-and-alcoholic-hepatitis-129412https://curecurrent.com/trials/the-georgia-latino-aids-hiv-diagnosis-and-linkage-in-youth-gladly-project-129413https://curecurrent.com/trials/revised-simplified-algorithm-for-treatment-eligibility-for-hiv-slateii-129414https://curecurrent.com/trials/simplified-algorithm-for-treatment-eligibility-129415https://curecurrent.com/trials/strategic-transformation-of-the-market-of-hcv-treatments-129416https://curecurrent.com/trials/effectiveness-of-nurse-delivered-care-for-adherence-mood-in-hiv-in-south-africa-129417https://curecurrent.com/trials/same-day-antiretroviral-therapy-with-bic-f-taf-129418https://curecurrent.com/trials/assess-the-downregulation-of-hiv-1-when-raltegravir-is-added-to-a-virologically-suppressed-haart-regimen-129419https://curecurrent.com/trials/smoking-cessation-using-motivational-therapy-and-varenicline-129420https://curecurrent.com/trials/antibody-response-to-prophylactic-qhpv-vaccine-at-48-months-among-hiv-infected-girls-and-boys-129421https://curecurrent.com/trials/study-of-topical-abi-1968-in-subjects-with-precancerous-cervical-lesions-from-human-papillomavirus-hpv-infection-129422https://curecurrent.com/trials/a-controlled-trial-to-evaluate-the-effects-of-ganedenbc30-on-the-immune-system-129423https://curecurrent.com/trials/open-label-study-of-dolutegravir-dtg-or-efavirenz-efv-for-human-immunodeficiency-virus-hiv-tuberculosis-tb-co-infection-129424https://curecurrent.com/trials/a-multilevel-gaming-intervention-for-persons-on-prep-129425https://curecurrent.com/trials/specimen-repository-for-hiv-immunopathogenesis-129426https://curecurrent.com/trials/electronic-capture-of-adherence-barriers-for-hiv-care-129427https://curecurrent.com/trials/psilocybin-assisted-group-therapy-for-demoralization-in-long-term-aids-survivors-129428https://curecurrent.com/trials/study-to-evaluate-the-efficacy-of-gs-9131-functional-monotherapy-in-human-immunodeficiency-virus-hiv-1-infected-adults-f-129429https://curecurrent.com/trials/phase-i-study-to-evaluate-a-human-monoclonal-antibody-mab-10e8vls-administered-alone-or-concurrently-with-mab-vrc07-523l-129430https://curecurrent.com/trials/design-and-development-of-a-mobile-app-to-improve-adherence-to-pre-exposure-prophylaxis-in-men-who-have-sex-with-men-129431https://curecurrent.com/trials/elite-controller-and-art-treated-hiv-statin-versus-asa-treatment-intervention-study-129432https://curecurrent.com/trials/gender-responsive-drug-use-treatment-for-juvenile-justice-girls-129433https://curecurrent.com/trials/prescribe-to-save-lives-129434https://curecurrent.com/trials/european-pregnancy-and-paediatric-infections-cohort-collaboration-paediatric-protocol-129435https://curecurrent.com/trials/a-study-of-mitoguazone-dihydrochloride-in-patients-with-aids-related-non-hodgkin-s-lymphoma-129436https://curecurrent.com/trials/motivational-interviewing-to-increase-prep-uptake-mi-prep-129437https://curecurrent.com/trials/alcohol-s-impact-on-inflammatory-markers-in-hiv-disease-russia-arch-cohort-129438https://curecurrent.com/trials/studying-partial-agonists-for-ethanol-and-tobacco-elimination-in-russians-with-hiv-st-peter-hiv-129439https://curecurrent.com/trials/using-social-media-to-deliver-hiv-self-testing-kits-and-link-to-online-prep-services-129440https://curecurrent.com/trials/investigating-chemotherapy-treatments-response-and-subsets-of-hiv-associated-kaposi-sarcoma-in-malawi-129441https://curecurrent.com/trials/police-training-to-reduce-occupational-needlesticks-and-hiv-among-substance-users-129442https://curecurrent.com/trials/mobile-based-application-mychoices-129443https://curecurrent.com/trials/integrating-hcv-and-hiv-screening-during-the-era-of-hiv-antigen-testing-129444https://curecurrent.com/trials/study-of-safety-tolerability-and-immunogenicity-of-gardasil-9-in-immunocompromised-patients-129445https://curecurrent.com/trials/reversing-tissue-fibrosis-to-improve-immune-reconstitution-in-hiv-129446https://curecurrent.com/trials/development-of-serologic-assays-for-human-herpes-virus-8-129447https://curecurrent.com/trials/a-chronological-study-of-the-formation-of-hiv-cellular-reservoirs-through-the-expression-of-surface-markers-on-cd4-t-lym-129448https://curecurrent.com/trials/cohorte-nationale-vih-2-129449https://curecurrent.com/trials/pharmacokinetics-of-once-daily-darunavir-ritonavir-in-hiv-infected-children-129450https://curecurrent.com/trials/a-drug-drug-interaction-study-between-daclatasvir-and-atazanavir-ritonavir-or-atazanavir-cobicistat-129451https://curecurrent.com/trials/bioequivalence-study-of-crushed-triumeq-with-or-without-drip-feed-compared-to-the-whole-tablet-129452https://curecurrent.com/trials/cohort-of-young-adults-infected-with-hiv-since-birth-or-during-childhood-129453https://curecurrent.com/trials/resilience-based-psychosocial-intervention-among-children-affected-by-hiv-aids-129454https://curecurrent.com/trials/kaletra-and-viread-in-antiretroviral-na-ve-patients-129455https://curecurrent.com/trials/pharmacokinetics-and-pharmacodynamics-of-dmpa-with-hiv-prep-129456https://curecurrent.com/trials/mmf-for-hiv-reservoir-reduction-129457https://curecurrent.com/trials/hiv-target-cell-response-in-women-initiating-various-contraceptive-methods-in-high-hiv-incidence-areas-zim-chic-129458https://curecurrent.com/trials/vicriviroc-sch-417690-treatment-protocol-in-human-immunodeficiency-virus-hiv-infected-participants-a-rollover-study-for-129459https://curecurrent.com/trials/project-first-financial-incentives-to-reduce-substance-use-and-improve-treatment-129460https://curecurrent.com/trials/use-of-hiv-self-test-kits-to-increase-identification-of-hiv-infected-individuals-and-their-partners-129461https://curecurrent.com/trials/pharmacokinetic-study-of-the-hcv-protease-inhibitor-boceprevir-and-the-hiv-integrase-inhibitor-raltegravir-129462https://curecurrent.com/trials/the-effect-of-phenytoin-on-the-pharmacokinetics-of-nevirapine-and-the-development-of-nevirapine-resistance-129463https://curecurrent.com/trials/the-influence-of-ginkgo-biloba-on-the-pharmacokinetics-of-the-ugt-substrate-raltegravir-ginger-129464https://curecurrent.com/trials/efficacy-of-antifolates-against-malaria-in-hiv-infected-pregnant-women-and-the-emergence-of-induced-resistance-in-plasmo-129465https://curecurrent.com/trials/pharmacokinetics-study-on-nevirapine-resistance-in-tanzania-129466https://curecurrent.com/trials/interaction-between-fosamprenavir-ritonavir-and-a-single-dose-olanzapine-forza-129467https://curecurrent.com/trials/covid-19-vaccine-chadox1-ncov-19-trial-in-south-african-adults-with-and-without-hiv-infection-129468https://curecurrent.com/trials/sustainable-adherence-and-prevention-of-hiv-drug-resistance-in-adolescents-129469https://curecurrent.com/trials/acceptability-and-feasibility-of-unsupervised-hiv-self-testing-among-networks-of-men-129470https://curecurrent.com/trials/atn-151-work-to-prevent-employment-as-hiv-prevention-129471https://curecurrent.com/trials/a-clinical-research-study-for-the-suppression-and-treatment-of-genital-herpes-infection-in-hiv-infected-persons-129472https://curecurrent.com/trials/age-related-clonal-haematopoiesis-in-an-hiv-evaluation-cohort-archive-129473https://curecurrent.com/trials/hiv-drug-resistance-pattern-due-to-migration-in-poland-129474https://curecurrent.com/trials/downmodulating-monocyte-activation-for-hiv-1-associated-neurocognitive-disorders-hand-129475https://curecurrent.com/trials/a-study-of-safety-reactogenicity-and-immunogenicity-of-hrv-vaccine-in-hiv-infected-infants-in-south-africa-129476https://curecurrent.com/trials/long-term-follow-up-of-food-and-cash-assistance-for-hiv-positive-men-and-women-on-antiretroviral-therapy-in-tanzania-129477https://curecurrent.com/trials/evaluation-of-artemisia-annua-and-moringa-129478https://curecurrent.com/trials/platelet-function-on-abacavir-and-tenofovir-129479https://curecurrent.com/trials/impact-of-hormonal-contraception-on-hiv-acquisition-and-transmission-risk-129480https://curecurrent.com/trials/chemsex-perceived-risks-and-coping-strategies-129481https://curecurrent.com/trials/mechanisms-of-impaired-hiv-associated-b-cell-and-pneumococcal-vaccine-responses-129482https://curecurrent.com/trials/effectiveness-of-peer-navigation-to-link-released-hiv-jail-inmates-to-hiv-care-129483https://curecurrent.com/trials/transgender-cohort-study-of-gender-affirmation-and-hiv-related-health-129484https://curecurrent.com/trials/community-based-antiretroviral-therapy-cbart-among-children-on-chronic-art-129485https://curecurrent.com/trials/effectiveness-of-peer-navigation-and-contingency-management-on-retention-in-hiv-care-129486https://curecurrent.com/trials/improving-engagement-in-hiv-care-for-high-risk-women-129487https://curecurrent.com/trials/postnaps-fi-nutrition-and-psychosocial-health-among-women-of-mixed-hiv-status-and-their-infants-in-gulu-uganda-129488https://curecurrent.com/trials/a-women-focused-prep-intervention-129489https://curecurrent.com/trials/pii-ngima-consequences-of-water-insecurity-for-maternal-and-child-health-129490https://curecurrent.com/trials/pharmacokinetic-and-safety-study-of-raltegravir-and-atazanavir-in-a-once-daily-dose-regimen-in-hiv-1-infected-patients-129491https://curecurrent.com/trials/pharmacokinetic-study-of-rosuvastatin-and-lopinavir-ritonavir-in-hiv-patients-129492https://curecurrent.com/trials/pharmacokinetic-study-of-two-generic-co-formulations-of-lopinavir-ritonavir-for-hiv-infected-children-surf-129493https://curecurrent.com/trials/drug-interaction-study-between-atovaquone-and-antiretroviral-agents-in-hiv-1-infected-patients-129494https://curecurrent.com/trials/pharmacokinetic-study-of-posaconazole-boosted-fosamprenavir-129495https://curecurrent.com/trials/assessment-of-a-community-support-worker-intervention-for-persons-living-with-hiv-plwh-in-rural-ethiopia-129496https://curecurrent.com/trials/inflammation-and-co-infections-in-d-eft-129497https://curecurrent.com/trials/development-and-feasibility-testing-of-a-mobile-phone-based-hiv-primary-care-engagement-intervention-129498https://curecurrent.com/trials/study-to-evaluate-safety-pharmacokinetics-and-antiviral-activity-of-bictegravir-gs-9883-in-human-immunodeficiency-virus-129499https://curecurrent.com/trials/anal-cancer-screening-study-129500https://curecurrent.com/trials/using-less-neurotoxic-drugs-in-patients-with-hand-marand-x-129501https://curecurrent.com/trials/pharmacokinetics-of-maraviroc-and-boosted-atazanavir-dual-regimen-in-stable-hiv-infected-patients-129502https://curecurrent.com/trials/opioid-relapse-hiv-risk-48-versus-24-weeks-of-injectable-extended-release-naltrexone-129503https://curecurrent.com/trials/efficacy-of-art-to-interrupt-hiv-transmission-networks-129504https://curecurrent.com/trials/quantitative-hpv-genotyping-in-screening-of-anal-intraepithelial-neoplasia-in-hiv-positive-patients-129505https://curecurrent.com/trials/digital-health-promotion-in-iringa-tanzania-129506https://curecurrent.com/trials/screening-test-accuracy-of-gynocular-hr-hpv-testing-via-for-detection-of-cervical-neoplastic-lesions-in-women-living-wit-129507https://curecurrent.com/trials/a-novel-approach-to-community-based-hiv-testing-with-traditional-healers-in-mwanza-tanzania-129508https://curecurrent.com/trials/immunogenetic-modulators-of-mucosal-protection-from-hiv-1-129509https://curecurrent.com/trials/study-of-late-boost-strategies-for-hiv-uninfected-participants-from-protocol-rv-144-129510https://curecurrent.com/trials/motivation-matters-study-129511https://curecurrent.com/trials/kaletra-and-maraviroc-in-antiretroviral-therapy-art-naive-patients-kalmar-study-129512https://curecurrent.com/trials/pilot-study-of-financial-incentives-for-ymsm-for-hiv-testing-and-prep-129513https://curecurrent.com/trials/delivery-optimization-for-antiretroviral-therapy-the-do-art-study-129514https://curecurrent.com/trials/study-of-the-effect-of-atorvastatin-for-reducing-aging-related-complication-in-hiv-infected-patients-older-than-45-years-129515https://curecurrent.com/trials/rural-prep-delivery-129516https://curecurrent.com/trials/a-two-part-study-to-compare-a-tablet-and-capsule-formulation-of-gsk2838232-with-and-without-food-and-to-assess-the-safet-129517https://curecurrent.com/trials/epidemiological-and-clinical-description-of-women-living-with-hiv-in-selected-countries-of-latin-america-129518https://curecurrent.com/trials/interval-varying-intervals-of-art-to-improve-outcomes-in-hiv-129519https://curecurrent.com/trials/tocilizumab-for-kshv-associated-multicentric-castleman-disease-129520https://curecurrent.com/trials/vrc-605-safety-and-pharmacokinetics-of-a-human-monoclonal-antibody-vrc-hivmab075-00-ab-vrc07-523ls-administered-intraven-129521https://curecurrent.com/trials/tb-lam-in-the-diagnosis-of-tb-129522https://curecurrent.com/trials/b-f-taf-ease-of-swallowability-trial-129523https://curecurrent.com/trials/efavirenz-400mg-in-treatment-na-ve-chinese-hiv-infected-patients-129524https://curecurrent.com/trials/n-803-combined-with-the-broadly-neutralizing-antibodies-plus-or-minus-hank-cells-for-hiv-129525https://curecurrent.com/trials/a-multidisciplinary-integrated-management-team-to-improve-maternal-child-outcomes-improve-intervention-to-improve-matern-129526https://curecurrent.com/trials/long-term-immunogenicity-of-the-hiv-gp120-neftat-as01b-vaccine-gsk-sb732461-129527https://curecurrent.com/trials/pharmacokinetic-drug-interaction-study-between-raltegravir-and-atorvastatin-129528https://curecurrent.com/trials/bone-mineral-density-in-human-immunodeficiency-virus-type-1-hiv-1-infected-adult-subjects-switching-from-a-tenofovir-reg-129529https://curecurrent.com/trials/sustainable-hiv-risk-reduction-strategies-for-probationers-129530https://curecurrent.com/trials/the-pharmacokinetic-study-of-saquinavir-new-tablet-formulation-in-hiv-infected-pregnant-women-129531https://curecurrent.com/trials/medication-adherence-and-outcomes-among-patients-in-united-states-with-hiv-129532https://curecurrent.com/trials/systematic-empirical-vs-test-guided-anti-tb-treatment-impact-in-severely-immunosuppressed-hiv-infected-adults-initiating-129533https://curecurrent.com/trials/the-influence-of-raltegravir-on-pravastatin-pharmacokinetics-grappa-129534https://curecurrent.com/trials/pharmacokinetic-drug-drug-interaction-study-between-raltegravir-and-citalopram-in-healthy-subjects-recital-129535https://curecurrent.com/trials/pharmacokinetic-study-on-raltegravir-and-lamotrigine-129536https://curecurrent.com/trials/viral-and-antiretroviral-dynamics-in-hiv-1-mother-to-child-transmission-fluids-129537https://curecurrent.com/trials/hiv-pre-exposure-prophylaxis-implementation-study-in-south-korea-129538https://curecurrent.com/trials/targeting-non-virally-suppressed-adults-with-alcohol-use-disorder-in-hiv-primary-care-129539https://curecurrent.com/trials/reducing-alcohol-dependence-among-hiv-positive-individuals-129540https://curecurrent.com/trials/toward-safer-opioid-prescribing-for-chronic-pain-in-high-risk-populations-129541https://curecurrent.com/trials/improving-cervical-cancer-screening-among-hiv-infected-women-in-india-129542https://curecurrent.com/trials/adhoc-mindfulness-based-research-129543https://curecurrent.com/trials/community-based-screening-for-hiv-self-testing-in-fsw-in-23-priority-districts-in-indonesia-129544https://curecurrent.com/trials/assessing-the-preliminary-effects-of-a-multisectoral-agricultural-intervention-on-adolescent-girls-health-129545https://curecurrent.com/trials/the-incidence-and-severity-of-drug-interactions-before-and-after-switching-antiretroviral-therapy-to-bictegravir-emtrici-129546https://curecurrent.com/trials/statins-for-pulmonary-and-cardiac-complications-of-chronic-hiv-coordinating-center-129547https://curecurrent.com/trials/supporting-treatment-adherence-readiness-through-training-start-129548https://curecurrent.com/trials/mobile-health-application-to-improve-hiv-medication-adherence-129549https://curecurrent.com/trials/pilot-of-mpowerment-for-young-men-who-have-sex-with-men-ymsm-in-beirut-129550https://curecurrent.com/trials/prevalence-of-covid-19-infection-in-a-cohort-of-patients-infected-by-the-hiv-and-patients-taking-prep-129551https://curecurrent.com/trials/effectiveness-of-an-online-prevention-program-in-reducing-the-risk-of-std-infection-in-young-adults-129552https://curecurrent.com/trials/study-on-the-response-to-tetanus-vaccination-of-people-living-with-hiv-129553https://curecurrent.com/trials/evaluation-of-drug-interaction-between-hs-10234-and-emtriccitabine-129554https://curecurrent.com/trials/dolutegravir-expanded-access-study-129555https://curecurrent.com/trials/novel-approaches-to-reducing-tobacco-related-harm-129556https://curecurrent.com/trials/traditional-healers-as-adherence-partners-for-persons-living-with-hiv-in-rural-mozambique-129557https://curecurrent.com/trials/reducing-hiv-risk-among-adolescents-evaluating-heart-for-teens-129558https://curecurrent.com/trials/prolifica-west-african-treatment-cohort-for-hepatitis-b-129559https://curecurrent.com/trials/a-study-of-mk-8527-in-human-immunodeficiency-type-1-virus-hiv-1-infected-participants-mk-8527-002-129560https://curecurrent.com/trials/interest-of-karate-kata-practice-on-the-self-esteem-of-patients-living-with-hiv-129561https://curecurrent.com/trials/methadone-morphine-or-oxycodone-in-treating-pain-in-patients-with-cancer-129562https://curecurrent.com/trials/package-of-care-to-improve-retention-in-art-and-mortality-among-treatment-naive-hiv-infected-individuals-129563https://curecurrent.com/trials/mhealth-for-art-adherence-by-hiv-african-americans-129564https://curecurrent.com/trials/effect-of-rifabutin-on-the-pharmacokinetics-of-oral-cabotegravir-in-healthy-subjects-129565https://curecurrent.com/trials/assessment-of-age-related-hearing-loss-in-hiv-1-patients-129566https://curecurrent.com/trials/workplace-based-hiv-self-testing-among-men-in-uganda-wise-men-129567https://curecurrent.com/trials/the-progirls-study-129568https://curecurrent.com/trials/developing-a-functional-cure-for-hiv-disease-clinical-specimen-collection-from-hiv-positive-individuals-129569https://curecurrent.com/trials/a-clinical-trial-of-pgdm1400-and-pgt121-and-vrc07-523ls-monoclonal-antibodies-in-hiv-infected-and-hiv-uninfected-adults-129570https://curecurrent.com/trials/evaluation-of-presumptive-periodic-treatment-ppt-of-sexually-transmitted-infections-stis-129571https://curecurrent.com/trials/pet-evaluation-of-brain-peripheral-benzodiazepine-receptors-using-11c-pbr28-in-hiv-seropositive-patients-with-mcmd-129572https://curecurrent.com/trials/depression-intervention-among-gay-and-bisexual-men-receiving-treatment-for-methamphetamine-use-129573https://curecurrent.com/trials/activating-treatment-as-prevention-through-community-mobilization-in-south-africa-129574https://curecurrent.com/trials/behavioral-depression-treatment-for-african-american-hiv-infected-substance-users-129575https://curecurrent.com/trials/fistula-formation-and-successful-repair-129576https://curecurrent.com/trials/western-australian-pre-exposure-prophylaxis-for-hiv-implementation-trial-129577https://curecurrent.com/trials/obstructive-sleep-apnea-cpap-treatment-cognitive-ability-in-hiv-129578https://curecurrent.com/trials/safety-and-effectiveness-of-3-doses-of-crofelemer-compared-to-placebo-in-the-treatment-of-hiv-associated-diarrhea-129579https://curecurrent.com/trials/evaluation-of-switching-from-current-cart-to-triumeq-with-adherence-support-will-enhance-hiv-control-in-vulnerable-popul-129580https://curecurrent.com/trials/information-visualizations-to-facilitate-hiv-related-patient-provider-communication-info-viz-hiv-129581https://curecurrent.com/trials/goal-management-training-executive-functions-and-hiv-129582https://curecurrent.com/trials/safety-and-tolerability-of-crofelemer-for-hiv-associated-diarrhea-129583https://curecurrent.com/trials/chws-mhealth-and-combination-hiv-prevention-129584https://curecurrent.com/trials/safety-and-efficacy-of-1proteinase-inhibitor-1pi-in-hiv-disease-129585https://curecurrent.com/trials/development-and-preliminary-trial-of-a-brief-portable-health-intervention-for-rural-sexual-minority-emerging-adults-129586https://curecurrent.com/trials/optimizing-retention-in-care-and-adherence-to-anti-retroviral-therapy-amongst-adolescents-living-with-hiv-in-rwanda-129587https://curecurrent.com/trials/body-compartment-pharmacokinetics-of-anti-retroviral-agents-that-may-be-used-for-future-hiv-post-exposure-prophylaxis-129588https://curecurrent.com/trials/does-rosuvastatin-delay-progression-of-atherosclerosis-in-hiv-129589https://curecurrent.com/trials/effect-of-atazanavir-ritonavir-on-the-pharmacokinetics-and-toxicity-of-lumefantrine-129590https://curecurrent.com/trials/pharmacokinetics-study-of-gsk1265744-in-subjects-with-severe-renal-impairment-129591https://curecurrent.com/trials/effect-of-gsk3640254-on-the-pharmacokinetics-of-a-combination-oral-contraceptive-129592https://curecurrent.com/trials/a-relative-bioavailability-and-food-effect-study-of-gsk3640254-tablet-and-capsule-formulations-in-healthy-participants-129593https://curecurrent.com/trials/condom-performance-in-a-longitudinal-enhanced-assessment-of-user-experiences-129594https://curecurrent.com/trials/st-petersburg-pain-and-alcohol-intervention-with-naltrexone-and-nalmefene-129595https://curecurrent.com/trials/optimizing-iron-status-while-minimizing-morbidity-in-hiv-infected-ugandan-children-129596https://curecurrent.com/trials/effect-of-cenicriviroc-on-hiv-neurocognitive-impairment-129597https://curecurrent.com/trials/ccr5-inhibitor-treatment-intensification-on-cd4-t-cell-recovery-129598https://curecurrent.com/trials/triple-vs-double-therapy-in-na-ves-hiv-infected-patients-129599https://curecurrent.com/trials/evaluating-an-hiv-risk-screening-tool-for-orphans-and-vulnerable-children-in-tanzania-129600https://curecurrent.com/trials/effects-of-a-protein-calorie-supplement-in-hiv-infected-women-with-tuberculosis-129601https://curecurrent.com/trials/chloroquine-outpatient-treatment-evaluation-for-hiv-covid-19-129602https://curecurrent.com/trials/raltegravir-intensification-in-hiv-infected-patients-129603https://curecurrent.com/trials/integrating-hiv-and-depression-self-care-to-improve-adherence-in-perinatal-women-129604https://curecurrent.com/trials/preventing-treating-hiv-comorbidities-in-india-multi-tiered-strategy-for-women-129605https://curecurrent.com/trials/maraviroc-as-an-immunomodulatory-drug-for-antiretroviral-treated-hiv-infected-patients-exhibiting-immunologic-failure-129606https://curecurrent.com/trials/telemedicine-in-hiv-care-in-buenos-aires-129607https://curecurrent.com/trials/efficacy-of-400-mg-efavirenz-versus-standard-600-mg-dose-in-hiv-tb-co-infected-patients-129608https://curecurrent.com/trials/promoting-repeated-hiv-self-testing-among-msm-in-hong-kong-129609https://curecurrent.com/trials/a-sleep-program-to-improve-sleep-quality-in-people-with-hiv-129610https://curecurrent.com/trials/vaccine-therapy-in-preventing-human-papillomavirus-infection-in-young-hiv-positive-male-patients-who-have-sex-with-males-129611https://curecurrent.com/trials/a-cluster-randomised-trial-of-community-led-distribution-of-hiv-self-tests-in-rural-malawi-hiv-self-testing-africa-star-129612https://curecurrent.com/trials/pharmacokinetic-study-of-pitavastatin-and-ritonavir-boosted-darunavir-or-efavirenz-129613https://curecurrent.com/trials/euphorbia-kansui-and-hiv-aids-functional-cure-129614https://curecurrent.com/trials/detecting-anal-and-genital-human-papillomavirus-infection-and-squamous-intraepithelial-lesions-in-hiv-positive-patients-129615https://curecurrent.com/trials/mindfulness-based-stress-reduction-for-older-adults-with-hiv-associated-neurocognitive-disorders-129616https://curecurrent.com/trials/study-of-blood-and-tissue-samples-from-patients-with-aggressive-non-hodgkin-b-cell-lymphoma-or-hodgkin-lymphoma-129617https://curecurrent.com/trials/a-clinical-trial-to-evaluate-the-efficacy-and-safety-of-elvitegravir-cobicistat-emtricitabine-tenofovir-alafenamide-as-a-129618https://curecurrent.com/trials/safety-study-of-a-dual-anti-hiv-gene-transfer-construct-to-treat-hiv-1-infection-129619https://curecurrent.com/trials/addressing-overdose-risk-among-recently-incarcerated-people-living-with-hiv-aids-129620https://curecurrent.com/trials/impact-of-metformin-on-immuno-virologic-parameters-in-hiv-129621https://curecurrent.com/trials/costs-efficiency-and-the-role-of-management-in-hiv-prevention-interventions-for-female-sex-workers-in-nigeria-129622https://curecurrent.com/trials/a-study-to-evaluate-pharmacokinetic-pk-and-safety-of-gsk1265744-in-subjects-with-hepatic-impairment-and-control-healthy-129623https://curecurrent.com/trials/latency-and-early-neonatal-provision-of-antiretroviral-drugs-clinical-trial-129624https://curecurrent.com/trials/infrared-coagulator-ablation-or-observation-in-preventing-anal-cancer-in-hiv-positive-patients-with-anal-neoplasia-129625https://curecurrent.com/trials/continuation-of-protease-inhibitor-based-second-line-therapy-vs-switch-to-b-f-taf-in-virologically-suppressed-adults-129626https://curecurrent.com/trials/comparing-two-types-of-swabs-in-collecting-cell-samples-for-anal-pap-tests-and-human-papillomavirus-tests-in-men-who-hav-129627https://curecurrent.com/trials/integrated-care-icare-at-mount-sinai-to-improve-substance-use-diagnosis-and-treatment-practices-in-hiv-clinic-settings-129628https://curecurrent.com/trials/transgender-education-for-affirmative-and-competent-hiv-and-healthcare-129629https://curecurrent.com/trials/dolutegravir-pediatric-liquid-formulation-study-129630https://curecurrent.com/trials/virological-suppression-in-hiv-positive-patients-involved-in-a-novel-standardized-adherence-protocol-129631https://curecurrent.com/trials/early-fast-track-versus-standard-care-for-persons-with-hiv-initiating-tld-129632https://curecurrent.com/trials/valganciclovir-to-reduce-t-cell-activation-in-hiv-infection-129633https://curecurrent.com/trials/a-prospective-observational-study-of-hiv-infected-pregnant-women-and-their-infants-at-clinical-sites-in-latin-american-a-129634https://curecurrent.com/trials/nucleosides-and-darunavir-dolutegravir-in-africa-129635https://curecurrent.com/trials/nisdi-pediatric-latin-american-countries-epidemiologic-study-places-a-prospective-observational-study-of-hiv-infected-ch-129636https://curecurrent.com/trials/point-of-care-viral-load-testing-among-hiv-infected-adolescents-in-haiti-129637https://curecurrent.com/trials/pith-moromo-2-cohort-to-study-health-consequences-of-food-and-nutrition-insecurity-during-pregnancy-and-lactation-129638https://curecurrent.com/trials/biomarkers-in-blood-samples-from-patients-with-hiv-infection-and-stage-iii-or-stage-iv-hodgkin-lymphoma-undergoing-chemo-129639https://curecurrent.com/trials/drug-drug-interactions-between-antiretroviral-drugs-and-cardiovascular-drugs-in-elderly-patients-129640https://curecurrent.com/trials/multi-interventional-study-exploring-hiv-1-residual-replication-a-step-towards-hiv-1-eradication-and-sterilizing-cure-129641https://curecurrent.com/trials/comparison-of-treatment-failure-criteria-in-hiv-infected-children-in-uganda-129642https://curecurrent.com/trials/multimedia-worth-with-black-drug-involved-women-on-probation-129643https://curecurrent.com/trials/personalized-information-or-basic-information-in-helping-patients-make-decisions-about-participating-in-a-clinical-trial-129644https://curecurrent.com/trials/a-pilot-trial-of-an-individualized-web-based-condom-use-intervention-129645https://curecurrent.com/trials/effect-of-evolocumab-on-coronary-endothelial-function-129646https://curecurrent.com/trials/evaluating-the-effectiveness-of-point-of-care-diagnostic-technologies-in-mch-services-in-mozambique-129647https://curecurrent.com/trials/potlako-a-programmatic-intervention-to-improve-access-to-timely-oncology-care-129648https://curecurrent.com/trials/3bnc117-monoclonal-antibody-in-hiv-infected-subjects-during-treatment-interruption-129649https://curecurrent.com/trials/multilevel-integration-strategies-to-enhance-service-provider-networks-in-vietnam-129650https://curecurrent.com/trials/virologic-treatment-failure-and-drug-resistance-in-hiv-infected-kenyan-children-respect-129651https://curecurrent.com/trials/raltegravir-lopinavir-ritonavir-versus-efavirenz-tenofovir-emtricitabine-in-treatment-naive-patients-129652https://curecurrent.com/trials/assessing-long-term-ctn-0049-outcomes-hcv-prevalence-and-progression-along-the-hcv-care-continuum-among-hiv-hcv-co-infec-129653https://curecurrent.com/trials/assess-the-seroconversion-status-of-health-care-workers-suspected-or-confirmed-cases-of-covid-19-patients-129654https://curecurrent.com/trials/clinical-trial-to-evaluate-pharmacological-interactions-between-hydroxybutyrate-ghb-and-cobicistat-129655https://curecurrent.com/trials/evaluation-of-safety-and-immunogenicity-of-a-human-papillomavirus-hpv-vaccine-in-human-immunodeficiency-virus-hiv-infect-129656https://curecurrent.com/trials/second-line-therapy-antiretroviral-in-patients-who-failed-non-nucleoside-reverse-transcriptase-inhibitor-nnrti-based-reg-129657https://curecurrent.com/trials/neurocognitive-impairment-and-psychiatric-comorbidities-in-hiv-1-129658https://curecurrent.com/trials/third-line-highly-active-antiretroviral-therapy-haart-in-hiv-infected-children-129659https://curecurrent.com/trials/efficacy-and-safety-of-single-versus-double-ritonavir-boosted-protease-inhibitor-pi-based-antiretroviral-therapy-art-reg-129660https://curecurrent.com/trials/the-pharmacokinetics-and-safety-of-idv-r-with-nrtis-in-hiv-tb-co-infected-patients-receiving-rifampicin-129661https://curecurrent.com/trials/pharmacogenomic-of-atazanavir-efavirenz-atv-efv-129662https://curecurrent.com/trials/tdm-of-generic-lopinavir-ritonavir-200-50-mg-129663https://curecurrent.com/trials/pharmacokinetic-study-of-2-doses-of-atv-r-od-2-nrtis-in-thai-hiv-1-infected-patients-129664https://curecurrent.com/trials/therapeutic-drug-monitoring-tdm-in-generic-tenofovir-lamivudine-efavirenz-129665https://curecurrent.com/trials/tdf-long-term-study-129666https://curecurrent.com/trials/pharmacokinetics-pk-and-safety-of-2-different-doses-of-lopinavir-ritonavir-in-in-hiv-tuberculosis-tb-co-infected-patient-129667https://curecurrent.com/trials/hepatitis-b-vaccination-hbv-in-hiv-infected-children-129668https://curecurrent.com/trials/pharmacokinetics-of-generic-lopinavir-ritonavir-in-pregnant-women-129669https://curecurrent.com/trials/efficacy-safety-study-comparing-2-doses-of-nvp-after-initiating-rifampin-containing-tb-therapy-129670https://curecurrent.com/trials/the-immunogenicity-of-varicella-zoster-virus-vaccine-in-hiv-infected-children-129671https://curecurrent.com/trials/aramchol-for-hiv-associated-nonalcoholic-fatty-liver-disease-and-lipodystrophy-129672https://curecurrent.com/trials/dose-reduction-of-lopinavir-in-children-129673https://curecurrent.com/trials/pharmacokinetics-of-low-dose-raltegravir-129674https://curecurrent.com/trials/a-study-to-test-the-efficacy-of-the-hbv-vaccine-and-to-look-at-the-prevalence-of-hbv-infection-129675https://curecurrent.com/trials/genotyping-directed-salvage-therapy-in-children-who-have-failed-dual-nrtis-129676https://curecurrent.com/trials/adherence-and-risk-behaviour-in-patients-with-hiv-infection-receiving-antiretroviral-therapy-129677https://curecurrent.com/trials/a-pharmacokinetic-study-of-once-daily-efavirenz-400-mg-versus-600-mg-in-thai-hiv-1-infected-subjects-129678https://curecurrent.com/trials/single-dose-truvada-study-129679https://curecurrent.com/trials/self-assessment-tuberculin-skin-test-129680https://curecurrent.com/trials/a-trial-of-vitamins-and-haart-in-hiv-disease-progression-129681https://curecurrent.com/trials/safety-study-of-a-tenofovir-containing-drug-regimen-for-the-prevention-of-mother-to-child-transmission-of-hiv-and-hbv-129682https://curecurrent.com/trials/artefill-for-the-treatment-of-hiv-associated-facial-lipoatrophy-129683https://curecurrent.com/trials/palliative-care-in-people-living-with-hiv-aids-integrating-into-standard-of-care-129684https://curecurrent.com/trials/pregnancy-in-women-with-hiv-infection-129685https://curecurrent.com/trials/study-to-evaluate-pharmacokinetics-safety-and-tolerability-of-dolutegravir-and-rilpivirine-juluca-50-milligram-mg-25-mg-129686https://curecurrent.com/trials/autologous-peripheral-stem-cell-transplant-in-treating-patients-with-non-hodgkin-s-lymphoma-or-hodgkin-s-lymphoma-129687https://curecurrent.com/trials/a-prospective-observational-study-of-individuals-who-seroconvert-while-taking-truvada-for-pre-exposure-prophylaxis-prep-129688https://curecurrent.com/trials/depression-therapy-to-improve-cardiovascular-risk-in-hiv-129689https://curecurrent.com/trials/piloting-at-birth-point-of-care-hiv-testing-strategies-in-kenya-129690https://curecurrent.com/trials/commit-hiv-trial-nepal-129691https://curecurrent.com/trials/makasi-intervention-for-african-and-caribbean-migrants-empowerment-in-sexual-health-in-paris-greater-area-129692https://curecurrent.com/trials/evaluation-of-the-hitsystem-to-improve-early-infant-diagnosis-outcomes-in-kenya-129693https://curecurrent.com/trials/smartphone-app-and-co-self-monitoring-for-smoking-cessation-129694https://curecurrent.com/trials/the-evaluations-of-cardiovascular-changes-in-long-term-treated-hiv-infected-individuals-129695https://curecurrent.com/trials/efficacy-of-efavirenz-400mg-vs-600mg-combined-with-lamivudine-and-tenofovir-in-treatment-naive-hiv-infection-129696https://curecurrent.com/trials/clinical-trial-to-evaluate-the-addition-to-an-antiretroviral-treatment-of-a-probiotic-129697https://curecurrent.com/trials/impaact-2015-evaluation-of-the-hiv-1-reservoir-in-the-central-nervous-system-of-perinatally-infected-youth-and-young-adu-129698https://curecurrent.com/trials/assessment-of-blood-vessel-density-in-kaposi-s-sarcoma-lesions-129699https://curecurrent.com/trials/investigation-of-the-psychosocial-factors-responsible-for-the-late-recourse-to-hiv-testing-within-msm-129700https://curecurrent.com/trials/free-hiv-testing-in-private-biological-laboratories-a-new-offer-to-encourage-hiv-testing-129701https://curecurrent.com/trials/project-minority-aids-prevention-reaching-black-and-hispanic-msm-about-prep-and-tasp-using-social-media-129702https://curecurrent.com/trials/preventing-bone-loss-among-chinese-patients-with-hiv-on-art-129703https://curecurrent.com/trials/hiv-persistence-and-viral-reservoirs-129704https://curecurrent.com/trials/short-term-disulfiram-administration-to-accelerate-the-decay-of-the-hiv-reservoir-in-antiretroviral-treated-hiv-infected-129705https://curecurrent.com/trials/a-multicenter-study-to-assess-the-tolerability-of-once-daily-lopinavir-ritonavir-lpv-r-liquid-versus-capsules-129706https://curecurrent.com/trials/liver-diseases-in-plwh-129707https://curecurrent.com/trials/cctg-595-text-messaging-intervention-to-improve-adherence-to-prep-in-high-risk-msm-129708https://curecurrent.com/trials/a-couple-based-relationship-strengthening-hiv-intervention-for-young-parents-129709https://curecurrent.com/trials/imaging-the-hiv-reservoir-129710https://curecurrent.com/trials/randomized-double-blind-trial-of-the-quadrivalent-hpv-vaccine-to-improve-responses-to-leep-treatment-of-cervical-hsil-129711https://curecurrent.com/trials/pharmacokinetic-study-of-cabotegravir-long-acting-in-healthy-adult-volunteers-129712https://curecurrent.com/trials/acceptance-and-compassion-to-enhance-self-care-pilot-129713https://curecurrent.com/trials/pilot-intervention-to-empower-hiv-clients-as-prevention-advocates-in-uganda-129714https://curecurrent.com/trials/community-based-cervical-cancer-prevention-and-education-among-women-living-with-hiv-129715https://curecurrent.com/trials/life-plans-intervention-study-129716https://curecurrent.com/trials/genetic-susceptibility-to-oncogenic-viruses-129717https://curecurrent.com/trials/immune-response-to-pneumococcal-vaccination-in-aging-hiv-positive-adults-129718https://curecurrent.com/trials/seroconversion-among-staff-at-a-large-acute-care-hospital-in-denmark-during-the-covid-19-pandemic-129719https://curecurrent.com/trials/intranasal-treatment-of-hiv-associated-neurocognitive-disorders-129720https://curecurrent.com/trials/cryptococcal-optimal-art-timing-trial-129721https://curecurrent.com/trials/preventing-bacterial-and-viral-infections-among-injection-drug-users-129722https://curecurrent.com/trials/adjunctive-sertraline-for-the-treatment-of-hiv-associated-cryptococcal-meningitis-129723https://curecurrent.com/trials/cryptococcal-antigen-screening-plus-sertraline-129724https://curecurrent.com/trials/improving-adherence-among-hiv-rwandan-youth-a-ti-cbte-indigenous-leader-model-129725https://curecurrent.com/trials/safety-and-immunogenicity-of-hivax-in-hiv-1-infected-subjects-129726https://curecurrent.com/trials/operational-research-for-cryptococcal-antigen-screening-129727https://curecurrent.com/trials/investigating-the-anti-human-immunodeficiency-virus-hiv-anti-inflammatory-effect-of-chloroquine-129728https://curecurrent.com/trials/longitudinal-study-of-dental-implant-therapy-in-hiv-positive-patients-129729https://curecurrent.com/trials/use-of-labeled-glucose-to-study-lymphocyte-replication-and-survival-in-hiv-infected-patients-129730https://curecurrent.com/trials/chemotherapy-and-haart-to-treat-aids-related-primary-brain-lymphoma-129731https://curecurrent.com/trials/safety-of-fmt-using-oral-encapsulated-prim-dj2727-in-hiv-129732https://curecurrent.com/trials/mhealth-intervention-of-hiv-and-stds-partner-notification-for-msm-129733https://curecurrent.com/trials/multi-sectoral-agricultural-intervention-to-improve-nutrition-health-and-developmental-outcomes-of-hiv-infected-and-affe-129734https://curecurrent.com/trials/hiv-buprenorphine-and-the-criminal-justice-system-stride2-129735https://curecurrent.com/trials/cervical-cancer-screening-in-cameroon-129736https://curecurrent.com/trials/hepatitis-b-virus-vaccination-in-hiv-positive-patients-and-individuals-at-high-risk-for-hiv-infection-129737https://curecurrent.com/trials/comparing-the-efficacy-of-enhanced-and-standard-htc-129738https://curecurrent.com/trials/dual-therapy-etravirine-raltegravir-by-once-daily-in-hiv-positive-patients-etral-qd-129739https://curecurrent.com/trials/childhood-acute-illness-and-nutrition-network-129740https://curecurrent.com/trials/a-new-approach-to-hiv-testing-adaptation-of-poct-for-pharmacies-to-reduce-risk-and-optimize-access-to-care-in-hiv-129741https://curecurrent.com/trials/comparative-effectiveness-of-brief-hiv-care-counseling-129742https://curecurrent.com/trials/treatment-of-acute-hepatitis-c-virus-in-hiv-co-infection-129743https://curecurrent.com/trials/project-rap-family-based-hiv-prevention-in-the-juvenile-drug-court-129744https://curecurrent.com/trials/pre-exposure-prophylaxis-accessibility-research-and-evaluation-2-129745https://curecurrent.com/trials/study-of-the-safety-tolerability-and-pharmacokinetics-of-tmb-607-in-hiv-negative-volunteers-129746https://curecurrent.com/trials/antiretroviral-therapy-selection-comparing-hiv-clinical-guidelines-with-hiv-assist-an-online-decision-support-tool-129747https://curecurrent.com/trials/a-web-based-intervention-study-to-reduce-high-risk-sexual-behavior-by-persons-living-with-hiv-aids-plwh-129748https://curecurrent.com/trials/development-of-a-couple-based-mobile-health-intervention-for-enhancing-hiv-care-engagement-outcomes-n-gage-129749https://curecurrent.com/trials/covid-19-infection-in-patients-infected-with-hiv-and-or-on-prep-129750https://curecurrent.com/trials/hiv-buprenorphine-and-the-criminal-justice-system-129751https://curecurrent.com/trials/short-term-disulfiram-administration-to-reverse-latent-hiv-infection-a-dose-escalation-study-129752https://curecurrent.com/trials/2-stage-cervical-cancer-screening-in-botswana-129753https://curecurrent.com/trials/adaptation-and-evaluation-of-the-pmtct-csc-in-dedza-and-ntcheu-districts-malawi-129754https://curecurrent.com/trials/optimizing-resilience-and-coping-in-hiv-via-internet-delivery-129755https://curecurrent.com/trials/behavioral-intervention-to-reduce-sexual-and-injection-risks-among-female-sex-workers-who-also-inject-drugs-in-mexico-129756https://curecurrent.com/trials/reaching-out-to-the-undiagnosed-people-infected-with-blood-borne-viral-infections-129757https://curecurrent.com/trials/evaluation-of-an-early-childhood-development-intervention-among-children-born-to-hiv-infected-women-in-eswatini-129758https://curecurrent.com/trials/hbv-hcv-hiv-in-belgian-prisons-129759https://curecurrent.com/trials/fecal-microbiota-transplantation-as-a-therapeutic-strategy-for-patients-infected-with-hiv-129760https://curecurrent.com/trials/an-open-label-pharmacokinetic-safety-and-efficacy-study-of-maraviroc-in-combination-with-background-therapy-for-the-trea-129761https://curecurrent.com/trials/trial-of-vitamin-d-in-hiv-progression-birth-outcomes-and-child-health-129762https://curecurrent.com/trials/clinical-characterisation-protocol-for-covid-19-in-people-living-with-hiv-129763https://curecurrent.com/trials/misc-cbo-in-children-affected-by-hiv-aids-129764https://curecurrent.com/trials/study-to-optimize-the-quality-of-samples-for-cell-mediated-immunity-cmi-in-art-na-ve-hiv-1-infected-subjects-129765https://curecurrent.com/trials/study-to-evaluate-the-effect-of-gsk3640254-on-the-pharmacokinetics-of-tenofovir-alafenamide-emtricitabine-129766https://curecurrent.com/trials/equivalence-of-boosted-atazanavir-based-regimens-and-currently-effective-haart-regimens-129767https://curecurrent.com/trials/pharmacokinetic-interactions-between-buprenorphine-and-tipranavir-ritonavir-129768https://curecurrent.com/trials/getting-to-zero-safer-conception-programming-among-hiv-sero-different-couples-in-uganda-129769https://curecurrent.com/trials/helping-men-have-healthy-babies-129770https://curecurrent.com/trials/shamba-maisha-pilot-agricultural-intervention-for-food-security-and-hiv-health-outcomes-in-kenya-129771https://curecurrent.com/trials/champs-study-chronic-hepatitis-c-management-to-improve-outcomes-129772https://curecurrent.com/trials/action-for-brain-health-now-ready-set-go-129773https://curecurrent.com/trials/using-social-media-to-improve-art-retention-and-treatment-outcomes-among-ylhiv-in-nigeria-129774https://curecurrent.com/trials/pyridostigmine-as-immunomodulator-in-people-living-with-hiv-129775https://curecurrent.com/trials/harnessing-the-power-of-text-messaging-to-invigorate-amsm-hiv-preventive-behavior-129776https://curecurrent.com/trials/supporting-adolescent-adherence-in-vietnam-saav-129777https://curecurrent.com/trials/safety-and-efficacy-of-bictegravir-emtricitabine-tenofovir-alafenamide-versus-dolutegravir-emtricitabine-tenofovir-alafe-129778https://curecurrent.com/trials/reducing-vulnerability-in-the-intimate-partnerships-of-female-sex-workers-sex-workers-129779https://curecurrent.com/trials/group-prenatal-care-for-reducing-the-risk-of-stds-in-pregnant-young-women-129780https://curecurrent.com/trials/buprenorphine-and-integrated-hiv-care-129781https://curecurrent.com/trials/reducing-sex-related-hiv-risk-behaviors-in-patients-receiving-treatment-for-opioid-dependence-129782https://curecurrent.com/trials/integration-of-mental-health-in-hiv-clinic-to-increase-the-success-of-arv-treatment-in-plwha-in-hospitals-129783https://curecurrent.com/trials/effectiveness-of-integrating-prenatal-care-in-reducing-hiv-stds-among-young-pregnant-women-129784https://curecurrent.com/trials/brief-introductory-therapy-for-opioid-dependence-129785https://curecurrent.com/trials/drv-r-rpv-qd-efficacy-and-toxicity-reduction-129786https://curecurrent.com/trials/randomized-open-label-phase-ii-trial-to-assess-the-safety-and-immunogenicity-of-mva-bn-smallpox-vaccine-in-immunocomprom-129787https://curecurrent.com/trials/disclosure-to-family-129788https://curecurrent.com/trials/adapting-the-hitsystem-to-support-prevention-of-mother-to-child-hiv-transmission-129789https://curecurrent.com/trials/hiv-risk-reduction-and-drug-abuse-treatment-in-malaysia-129790https://curecurrent.com/trials/evaluation-of-rapid-hiv-self-testing-among-msm-estamp-129791https://curecurrent.com/trials/hepatitis-b-en-haitian-immigrants-in-chile-molecular-characterization-and-determination-of-vaccine-response-129792https://curecurrent.com/trials/directly-observed-antiretroviral-therapy-among-active-drug-users-129793https://curecurrent.com/trials/comparing-food-and-cash-assistance-for-hiv-positive-men-and-women-on-antiretroviral-therapy-in-tanzania-129794https://curecurrent.com/trials/hiv-risk-reduction-and-drug-abuse-treatment-in-iran-129795https://curecurrent.com/trials/behavioral-drug-and-hiv-risk-reduction-counseling-in-methadone-patients-in-china-129796https://curecurrent.com/trials/abstinence-linked-money-management-multisite-129797https://curecurrent.com/trials/the-impact-of-pharmacists-interventions-on-the-quality-of-life-of-hiv-tb-co-infection-outpatients-in-indonesia-129798https://curecurrent.com/trials/doravirine-rifapentine-and-isoniazid-interaction-129799https://curecurrent.com/trials/effects-of-periodontal-treatment-on-hiv-infected-patients-129800https://curecurrent.com/trials/a-study-to-assess-relative-bioavailability-and-food-effect-of-new-formulations-of-gsk2248761-129801https://curecurrent.com/trials/depletion-of-serum-amyloid-p-component-to-enhance-the-immune-response-to-dna-vaccination-129802https://curecurrent.com/trials/hiv-reverse-cholesterol-transport-study-129803https://curecurrent.com/trials/prevalence-of-sexually-transmitted-infections-among-people-attending-the-sexual-assault-centre-in-oslo-norway-129804https://curecurrent.com/trials/mater-bronx-rapid-hiv-testing-project-129805https://curecurrent.com/trials/a-hiv-study-of-a-fixed-dose-combination-tablet-in-antiretroviral-experienced-patients-129806https://curecurrent.com/trials/new-tablet-containing-two-fda-approved-anti-hiv-drugs-for-antiretroviral-therapy-experienced-hiv-1-infected-subjects-129807https://curecurrent.com/trials/community-supported-risk-reduction-for-syringe-exchange-participants-129808https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetic-pk-interactions-between-gsk3640254-and-dolutegravir-dtg-129809https://curecurrent.com/trials/prevalence-of-hiv-ve-cases-with-aids-defining-opportunistic-infections-among-art-naive-patients-attending-art-centre-129810https://curecurrent.com/trials/improve-functional-health-status-in-minority-women-with-hiv-129811https://curecurrent.com/trials/naltrexone-for-opioid-dependent-released-human-immunodeficiency-virus-positive-hiv-criminal-justice-populations-129812https://curecurrent.com/trials/ibalizumab-plus-optimized-background-regimen-in-patient-with-multi-drug-resistant-hiv-129813https://curecurrent.com/trials/same-day-treatment-with-genvoya-vs-efv-tdf-3tc-129814https://curecurrent.com/trials/geriatric-hiv-cohort-in-sub-sahara-africa-129815https://curecurrent.com/trials/efficacy-of-group-intervention-to-reduce-stress-symptoms-129816https://curecurrent.com/trials/safety-and-immunogenicity-of-measles-vaccine-varicella-vaccine-and-hepatitis-a-vaccine-129817https://curecurrent.com/trials/aging-with-dignity-health-optimism-and-community-129818https://curecurrent.com/trials/effect-of-gender-and-hiv-infection-on-zidovudine-and-lamivudine-pharmacokinetics-129819https://curecurrent.com/trials/return-to-work-randomized-controlled-trial-counseling-after-fatigue-treatment-in-hiv-aids-129820https://curecurrent.com/trials/community-based-combination-hiv-prevention-in-tanzanian-women-129821https://curecurrent.com/trials/effects-and-safety-of-caspofungin-and-corticosteroids-in-pneumocystis-pneumonia-in-non-hiv-patients-129822https://curecurrent.com/trials/switch-study-to-evaluate-f-taf-in-hiv-1-positive-participants-who-are-virologically-suppressed-on-regimens-containing-ft-129823https://curecurrent.com/trials/incidence-of-human-immunodeficiency-virus-1-hiv-1-infection-in-hiv-1-uninfected-high-risk-men-who-have-sex-with-men-129824https://curecurrent.com/trials/the-effect-of-norethisterone-enanthate-on-recurrent-bacterial-vaginosis-129825https://curecurrent.com/trials/hiv-prevention-for-hiv-negative-men-via-reduction-of-social-anxiety-129826https://curecurrent.com/trials/phase-iii-clinical-study-of-azvudine-in-hiv-infected-treatment-naive-patients-129827https://curecurrent.com/trials/safety-and-efficacy-study-of-gsk2838232-in-human-immunodeficiency-virus-hiv-1-infected-adults-129828https://curecurrent.com/trials/gps-adaptation-trial-of-an-hiv-prevention-counselling-program-for-hiv-positive-and-hiv-negative-gay-and-bisexual-men-129829https://curecurrent.com/trials/intervention-research-to-reduce-hiv-sexual-transmission-among-hiv-positive-men-who-have-sex-with-men-129830https://curecurrent.com/trials/hiv-1-and-brain-interaction-on-smoking-comorbidity-129831https://curecurrent.com/trials/a-drug-interaction-study-investigating-the-effect-of-rifabutin-on-the-pharmacokinetics-of-maraviroc-129832https://curecurrent.com/trials/analysis-of-telmisartan-administered-with-antiretroviral-therapy-art-in-patients-with-acute-hiv-infection-129833https://curecurrent.com/trials/sankofa-pediatric-hiv-disclosure-intervention-129834https://curecurrent.com/trials/does-the-implementation-of-nurse-driven-hiv-screening-for-key-populations-in-the-emergency-departments-limit-undiagnosed-129835https://curecurrent.com/trials/behavioral-drug-and-hiv-risk-reduction-counseling-with-mmt-in-china-129836https://curecurrent.com/trials/gut-microbiota-changes-of-hiv-patients-before-and-after-one-year-of-art-129837https://curecurrent.com/trials/study-of-pentasa-for-reducing-residual-systemic-immune-activation-in-treated-hiv-infection-129838https://curecurrent.com/trials/ra-effect-on-cell-surface-molecules-in-vivo-129839https://curecurrent.com/trials/taf-for-hiv-hbv-with-renal-dysfunction-129840https://curecurrent.com/trials/switching-from-a-tenofovir-disoproxil-fumarate-tdf-containing-regimen-to-elvitegravir-cobicistat-emtricitabine-tenofovir-129841https://curecurrent.com/trials/mechanisms-of-immune-reconstitution-reduced-immune-activation-following-darunavir-based-art-129842https://curecurrent.com/trials/treatment-with-msc-in-hiv-infected-patients-with-controlled-viremia-and-immunological-discordant-response-129843https://curecurrent.com/trials/nafld-in-hiv-infected-patients-129844https://curecurrent.com/trials/nutritional-rehabilitation-in-senegalese-hiv-infected-children-and-adolescents-129845https://curecurrent.com/trials/ethnicity-data-in-hiv-positive-men-who-have-sex-with-men-129846https://curecurrent.com/trials/mk-8583-single-dose-study-in-human-immunodeficiency-virus-type-1-hiv-1-infected-participants-mk-8583-002-129847https://curecurrent.com/trials/therapeutic-vaccine-for-hiv-129848https://curecurrent.com/trials/open-label-safety-study-of-e-c-f-taf-genvoya-in-hiv-1-positive-patients-with-mild-to-moderate-renal-impairment-129849https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-e-c-f-taf-versus-e-c-f-tdf-in-hiv-1-positive-antiretroviral-treatment-naive-129850https://curecurrent.com/trials/eliminating-hepatitis-c-transmission-by-enhancing-care-and-treatment-among-hiv-co-infected-individuals-129851https://curecurrent.com/trials/evaluation-of-clinical-impacts-and-costs-of-ehealth-in-rwanda-129852https://curecurrent.com/trials/evaluation-of-the-neurological-and-psychiatric-adverse-events-of-dolutegravir-and-bictegravir-in-real-life-129853https://curecurrent.com/trials/evaluation-of-neurologic-and-psychiatric-adverse-events-of-several-antiretroviral-drugs-in-real-life-setting-129854https://curecurrent.com/trials/rifaximin-for-chronic-immune-activation-in-people-with-hiv-129855https://curecurrent.com/trials/randomized-placebo-controlled-trial-of-atorvastatin-in-hiv-positive-patients-not-on-antiretroviral-therapy-129856https://curecurrent.com/trials/hiv-self-testing-to-empower-prevention-choices-in-sex-workers-129857https://curecurrent.com/trials/vedolizumab-anti-alpha4beta7-in-subjects-with-hiv-infection-undergoing-analytical-treatment-interruption-129858https://curecurrent.com/trials/the-study-to-evaluate-the-safety-of-ub-421-in-combination-with-antiretroviral-therapy-art-and-the-efficacy-in-reduction-129859https://curecurrent.com/trials/home-hiv-testing-for-older-adults-in-south-africa-129860https://curecurrent.com/trials/safety-and-efficacy-of-reduced-versus-standard-dose-efavirenz-efv-plus-two-nucleotides-in-antiretroviral-na-ve-adults-129861https://curecurrent.com/trials/personalized-hiv-and-sti-testing-tool-129862https://curecurrent.com/trials/hiv-aids-alcohol-related-outcomes-translational-evidence-based-interventions-129863https://curecurrent.com/trials/evaluation-of-the-effectiveness-of-a-quality-improvement-intervention-129864https://curecurrent.com/trials/an-efficacy-and-safety-study-of-shrna-modified-cd34-cells-in-hiv-infected-patients-129865https://curecurrent.com/trials/dosing-of-tenofovir-and-efavirenz-in-antiretroviral-therapy-129866https://curecurrent.com/trials/optimization-of-antiretroviral-therapy-129867https://curecurrent.com/trials/affecting-the-epidemiology-of-hiv-in-uganda-129868https://curecurrent.com/trials/effectiveness-of-raltegravir-based-antiretroviral-therapy-in-hiv-hcv-coinfected-liver-transplant-recipients-129869https://curecurrent.com/trials/behavioral-therapy-development-for-methamphetamine-abusers-129870https://curecurrent.com/trials/hiv-drug-abuse-prevention-for-south-african-men-129871https://curecurrent.com/trials/safety-and-efficacy-of-grazoprevir-and-elbasvir-for-gt1ang-gt6-with-and-without-hiv-129872https://curecurrent.com/trials/fluorescence-spectroscopy-for-gut-permeability-assessment-129873https://curecurrent.com/trials/pharmacokinetics-and-safety-of-rifabutin-150-mg-once-daily-versus-rifabutin-300-mg-thrice-weekly-129874https://curecurrent.com/trials/hiv-1-infected-adult-subjects-with-hiv-associated-neurocognitive-disorders-despite-effective-antiretroviral-therapy-129875https://curecurrent.com/trials/the-impact-of-omega-three-fatty-acids-on-vascular-function-in-hiv-129876https://curecurrent.com/trials/point-of-care-viral-load-testing-to-enable-streamlined-care-and-task-shifting-for-chronic-hiv-care-129877https://curecurrent.com/trials/tenofovir-adherence-to-rapidly-guide-and-evaluate-prep-and-hiv-therapy-129878https://curecurrent.com/trials/therapeutic-drug-monitoring-study-of-reduced-dose-efavirenz-400-mg-in-combo-tablet-for-patients-receiving-atripla-with-v-129879https://curecurrent.com/trials/complementary-alternative-medicine-use-in-hiv-latinos-in-the-us-mexico-border-129880https://curecurrent.com/trials/feasibility-of-vaginal-progesterone-to-reduce-hiv-associated-preterm-birth-129881https://curecurrent.com/trials/prj2203-dolutegravir-post-authorization-safety-study-pass-129882https://curecurrent.com/trials/retrospective-study-to-determine-the-incidence-of-bone-fractures-in-hiv-infected-patients-in-spain-129883https://curecurrent.com/trials/botswana-tdf-ftc-oral-hiv-prophylaxis-trial-129884https://curecurrent.com/trials/a-phase-iv-open-label-randomised-pilot-clinical-trial-designed-to-evaluate-the-potential-neurotoxicity-of-dolutegravir-l-129885https://curecurrent.com/trials/hiv-awal-early-testing-treatment-indonesia-project-intervention-phase-129886https://curecurrent.com/trials/study-of-the-effectiveness-and-safety-of-darunavir-cobicistat-drv-c-containing-regimens-in-routine-clinical-practice-129887https://curecurrent.com/trials/peer-navigation-to-improve-engagement-in-care-for-hiv-positive-men-who-have-sex-with-men-in-ehlanzeni-south-africa-129888https://curecurrent.com/trials/effect-of-dolutegravir-on-etonogestrel-levels-in-hiv-infected-women-in-botswana-129889https://curecurrent.com/trials/switching-from-protease-inhibitor-pi-to-etravirine-in-hiv-1-infected-subjects-with-viremia-suppression-129890https://curecurrent.com/trials/neurological-monitoring-in-patients-switching-from-dolutegravir-based-regimen-to-bictegravir-based-regimen-129891https://curecurrent.com/trials/efficacy-and-security-of-annual-and-biennial-zoledronic-acid-for-osteoporosis-treatment-in-an-hiv-infected-patients-coho-129892https://curecurrent.com/trials/efficacy-of-treatment-intensification-with-maraviroc-on-hiv-1-viral-latency-in-recently-infected-hiv-1-na-ve-patients-st-129893https://curecurrent.com/trials/dose-ranging-study-of-gsk1265744-plus-nucleoside-reverse-transcriptase-inhibitors-for-induction-of-human-immunodeficienc-129894https://curecurrent.com/trials/evaluating-the-response-to-two-antiretroviral-medication-regimens-in-hiv-infected-pregnant-women-who-begin-antiretrovira-129895https://curecurrent.com/trials/effect-of-atorvastatin-on-subclinical-atherosclerosis-129896https://curecurrent.com/trials/123i-radiolabeled-3bnc117-129897https://curecurrent.com/trials/short-duration-therapy-of-acute-hepatitis-c-genotypes-1-or-4-129898https://curecurrent.com/trials/the-dolutegravir-antiretroviral-mono-therapy-for-hiv-trial-129899https://curecurrent.com/trials/cvctplus-a-couples-based-approach-to-linkage-to-care-and-arv-adherence-129900https://curecurrent.com/trials/family-centered-hiv-care-viral-suppression-and-retention-in-hiv-positive-children-swaziland-129901https://curecurrent.com/trials/repeated-dermavir-immunizations-in-hiv-1-infected-treatment-na-ve-patients-129902https://curecurrent.com/trials/switching-from-tenofovir-disoproxil-fumarate-to-abacavir-or-tenofovir-alafenamide-129903https://curecurrent.com/trials/prevalence-of-hcv-in-hiv-negative-msm-129904https://curecurrent.com/trials/mobile-media-rich-interactive-guideline-system-mmrigs-pilot-study-129905https://curecurrent.com/trials/tesamorelin-effects-on-liver-fat-and-histology-in-hiv-129906https://curecurrent.com/trials/effects-of-docosahexanoic-acid-on-neurocognitive-impairment-in-hiv-infected-patients-129907https://curecurrent.com/trials/digital-star-hiv-prevention-for-youth-in-mental-health-treatment-129908https://curecurrent.com/trials/tauroursodeoxycholic-acid-for-protease-inhibitor-associated-insulin-resistance-129909https://curecurrent.com/trials/a-randomized-pilot-trial-evaluating-the-impact-of-a-yoga-intervention-on-cognition-in-older-adults-infected-with-hiv-129910https://curecurrent.com/trials/youth-focused-strategies-to-promote-adherence-to-pre-exposure-prophylaxis-among-youth-at-risk-for-hiv-in-thailand-129911https://curecurrent.com/trials/development-of-an-hiv-self-testing-intervention-129912https://curecurrent.com/trials/mhealth-for-pre-exposure-prophylaxis-adherence-by-young-adult-msm-129913https://curecurrent.com/trials/maternal-hiv-trial-to-assist-disclosure-to-children-129914https://curecurrent.com/trials/impact-of-a-short-term-analytical-treatment-interruption-and-re-initiation-of-antiretroviral-therapy-on-immunologic-and-129915https://curecurrent.com/trials/pericardial-fat-and-inflammation-in-hiv-patients-and-controls-129916https://curecurrent.com/trials/safety-and-immunogenicity-of-anti-pneumococcal-vaccines-in-hiv-infected-pregnant-women-129917https://curecurrent.com/trials/treatment-with-immunological-checkpoint-inhibitors-of-hiv-infected-subjects-with-cancer-129918https://curecurrent.com/trials/chidamide-in-combination-with-antiretroviral-therapy-for-eradication-of-the-latent-hiv-1-reservoir-129919https://curecurrent.com/trials/the-impact-of-vct-and-condom-distribution-as-hiv-prevention-strategies-among-youth-in-kenya-129920https://curecurrent.com/trials/tenofovir-levonorgestrel-intravaginal-ring-and-tenofovir-intravaginal-ring-129921https://curecurrent.com/trials/tu-washindi-na-prep-adolescent-girls-in-kenya-taking-control-of-their-health-129922https://curecurrent.com/trials/host-genetic-factors-influencing-hiv1-and-hcv-viral-loads-and-aids-clinical-progression-in-a-hemophilia-cohort-hgds-3-129923https://curecurrent.com/trials/reducing-hepatitis-c-virus-hcv-human-immunodeficient-virus-hiv-risk-behaviors-among-injection-drug-users-in-china-129924https://curecurrent.com/trials/health-improvement-project-providence-129925https://curecurrent.com/trials/implication-for-strategies-of-long-term-control-of-viral-replication-in-patient-with-primary-hiv-infection-phi-129926https://curecurrent.com/trials/public-health-targeting-of-prep-at-hiv-positives-bridging-networks-129927https://curecurrent.com/trials/initiation-of-first-line-antiretroviral-treatment-with-tenofovir-alafenamide-emtricitabine-bictegravir-at-the-first-clin-129928https://curecurrent.com/trials/micro-rna-as-prediction-and-or-prognostic-markers-of-iris-in-tb-hiv-co-infected-patients-129929https://curecurrent.com/trials/women-share-study-reducing-sexual-risk-129930https://curecurrent.com/trials/effects-of-the-probiotic-visbiome-extra-strength-on-gut-microbiome-immune-activation-markers-129931https://curecurrent.com/trials/mobile-messaging-intervention-to-present-new-hiv-prevention-options-for-men-who-have-sex-with-men-msm-129932https://curecurrent.com/trials/hiv-accelerated-liver-disease-in-uganda-129933https://curecurrent.com/trials/pharmacodynamics-safety-and-pharmacokinetics-of-bms-663068-an-hiv-attachment-inhibitor-in-hiv-1-129934https://curecurrent.com/trials/safety-and-immunogenicity-of-glaxosmithkline-biologicals-hpv-vaccine-580299-cervarix-in-hiv-infected-females-129935https://curecurrent.com/trials/study-to-evaluate-switching-from-a-regimen-consisting-of-efavirenz-emtricitabine-tenofovir-disoproxil-fumarate-efv-ftc-t-129936https://curecurrent.com/trials/switch-study-to-evaluate-the-safety-and-efficacy-of-emtricitabine-rilpivirine-tenofovir-alafenamide-ftc-rpv-taf-fixed-do-129937https://curecurrent.com/trials/safety-and-efficacy-of-maraviroc-in-patients-for-hiv-patients-regulatory-post-marketing-commitment-plan-129938https://curecurrent.com/trials/implementation-and-evaluation-of-an-electronic-alert-to-encourage-targeted-screening-for-hiv-infection-at-foch-hospital-129939https://curecurrent.com/trials/living-well-project-for-persons-with-aids-129940https://curecurrent.com/trials/testing-an-intervention-to-increase-hiv-self-testing-among-young-black-msm-129941https://curecurrent.com/trials/switch-to-genvoya-followed-by-hcv-therapy-with-epclusa-followed-by-simplification-of-hiv-therapy-with-biktarvy-in-patien-129942https://curecurrent.com/trials/isoprinosine-in-hiv-patients-with-viral-load-50-y-200-copies-ml-129943https://curecurrent.com/trials/ihivarna-clinical-trial-in-hiv-infected-individuals-129944https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-glecaprevir-pibrentasvir-abt-493-abt-530-in-treatment-naive-and-treatment-129945https://curecurrent.com/trials/a-phase-i-iia-aeras-456-in-hiv-negative-adults-with-without-latent-tuberculosis-infection-c-035-456-129946https://curecurrent.com/trials/impact-evaluation-of-a-school-based-sexuality-and-hiv-prevention-education-activity-in-south-africa-129947https://curecurrent.com/trials/factors-mediating-gut-microbiota-dysbiosis-and-metabolic-disease-in-hiv-patients-129948https://curecurrent.com/trials/striving-towards-empowerment-and-medication-adherence-step-ad-129949https://curecurrent.com/trials/phase-i-study-of-hiv-adenoviral-vector-vaccine-in-healthy-subjects-using-needle-or-biojector-injection-129950https://curecurrent.com/trials/home-based-self-testing-a-cluster-randomized-controlled-trial-in-rural-lesotho-hoseng-129951https://curecurrent.com/trials/natural-history-study-of-hiv-acquired-in-infancy-or-childhood-129952https://curecurrent.com/trials/continuing-care-and-treatment-for-patients-with-cancer-aids-skin-disease-129953https://curecurrent.com/trials/the-use-of-a-distress-thermometer-in-a-pediatric-research-setting-an-exploratory-pilot-study-129954https://curecurrent.com/trials/treatment-of-heroin-and-cocaine-with-methadone-maintenance-and-contingency-management-129955https://curecurrent.com/trials/study-of-the-safety-and-pharmacokinetics-of-a-human-monoclonal-antibody-vrc-hivmab060-00-ab-vrc01-administered-intraveno-129956https://curecurrent.com/trials/intermittent-versus-continuous-haart-highly-active-antiretroviral-therapy-for-treating-chronic-hiv-infected-patients-in-129957https://curecurrent.com/trials/a-phase-i-trial-of-nelfinavir-viracept-in-adults-with-solid-tumors-129958https://curecurrent.com/trials/vrc-601-a-phase-i-open-label-dose-escalation-study-of-the-safety-and-pharmacokinetics-of-a-human-monoclonal-antibody-vrc-129959https://curecurrent.com/trials/magnetic-resonance-imaging-of-the-face-and-bones-129960https://curecurrent.com/trials/the-second-multicenter-hemophilia-cohort-study-129961https://curecurrent.com/trials/safety-and-pharmacokinetics-of-a-human-monoclonal-antibody-vrc-hivmab080-00-ab-vrc01ls-with-broad-hiv-1-neutralizing-act-129962https://curecurrent.com/trials/short-adherence-intervention-for-viral-re-suppression-129963https://curecurrent.com/trials/study-of-safety-and-immunogenicity-of-hiv-vaccines-in-healthy-volunteers-129964https://curecurrent.com/trials/effects-of-diet-on-brain-processing-129965https://curecurrent.com/trials/immune-responses-to-two-experimental-hiv-vaccines-in-healthy-adults-129966https://curecurrent.com/trials/sexually-active-adolescent-focused-education-129967https://curecurrent.com/trials/mild-neurocognitive-disorder-in-hiv-infection-of-the-brain-129968https://curecurrent.com/trials/viral-and-immunologic-factors-contributing-to-the-lack-of-hiv-transmission-among-couples-in-rakai-uganda-129969https://curecurrent.com/trials/epidemiological-study-of-hiv-in-the-south-african-national-defense-force-129970https://curecurrent.com/trials/impact-of-sirolimus-and-maraviroc-on-ccr5-expression-and-the-hiv-1-reservoir-in-hiv-infected-kidney-transplant-recipient-129971https://curecurrent.com/trials/phase-1-safety-study-of-two-experimental-hiv-vaccines-129972https://curecurrent.com/trials/a-semi-factorial-cluster-randomized-trial-to-estimate-the-effect-size-of-community-mobilization-and-vct-vans-on-the-adop-129973https://curecurrent.com/trials/aripiprazole-for-prevention-of-relapse-to-cocaine-use-in-methadone-maintenance-patients-129974https://curecurrent.com/trials/immune-and-viral-status-of-hiv-infected-patients-after-stopping-combination-antiretroviral-therapy-129975https://curecurrent.com/trials/internet-based-videoconferencing-to-address-alcohol-use-and-pain-129976https://curecurrent.com/trials/video-information-provider-for-hiv-associated-non-aids-vip-hana-symptoms-129977https://curecurrent.com/trials/effects-of-potent-antiretroviral-therapy-on-kaposi-s-sarcoma-129978https://curecurrent.com/trials/bay-43-9006-sorafenib-to-treat-patients-with-kaposi-s-sarcoma-129979https://curecurrent.com/trials/an-exploratory-study-of-the-use-of-five-wishes-as-a-tool-for-advanced-care-planning-in-young-adults-with-metastatic-recu-129980https://curecurrent.com/trials/relationship-of-viral-resistance-development-to-cd4-monitoring-alone-or-with-viral-load-monitoring-129981https://curecurrent.com/trials/a-pragmatic-randomised-study-to-optimise-screening-prevention-and-care-for-tuberculosis-in-malawi-129982https://curecurrent.com/trials/a-community-university-approach-to-preventing-hiv-129983https://curecurrent.com/trials/losartan-to-reduce-inflammation-and-fibrosis-endpoints-in-hiv-trial-129984https://curecurrent.com/trials/the-influence-of-ritonavir-alone-and-in-combination-with-lopinavir-on-fenofibric-acid-pharmacokinetics-in-healthy-volunt-129985https://curecurrent.com/trials/to-assess-the-relative-bioavailability-ba-of-triumeq-and-dolutegravir-and-lamivudine-dtg-3tc-pediatric-dispersible-table-129986https://curecurrent.com/trials/theory-based-hiv-disclosure-intervention-for-parents-129987https://curecurrent.com/trials/clinical-trial-to-assess-the-security-of-the-dose-reduction-of-ritonavir-in-hiv-infected-patients-in-treatment-with-tipr-129988https://curecurrent.com/trials/trial-about-hepatic-security-of-antiretroviral-treatment-based-on-kaletra-versus-nevirapine-in-co-infected-hiv-hcv-patie-129989https://curecurrent.com/trials/immune-responses-to-mycobacterium-tuberculosis-129990https://curecurrent.com/trials/screening-protocol-for-hiv-vaccine-studies-129991https://curecurrent.com/trials/peginterferon-alfa-2a-ribavirin-and-epoetin-in-coinfected-patients-hcv-hiv-not-responding-to-previous-treatment-regimens-129992https://curecurrent.com/trials/evaluate-the-efficacy-and-security-of-darunavir-ritonavir-900-100-mg-once-a-day-as-an-antiretroviral-treatment-simplific-129993https://curecurrent.com/trials/study-to-compare-the-virologic-efficacy-in-cerebrospinal-fluid-csf-and-neurocognitive-state-in-patients-infected-by-hiv-129994https://curecurrent.com/trials/clinical-trial-assessing-once-daily-raltegravir-administration-800-mg-qd-in-hiv-1-infected-patients-receiving-unboosted-129995https://curecurrent.com/trials/socioenvironmental-determinants-of-psychological-functioning-mental-health-and-aids-in-mali-129996https://curecurrent.com/trials/hepatitis-b-and-hiv-co-infection-in-patients-in-uganda-129997https://curecurrent.com/trials/pilot-study-to-compare-the-pharmacokinetics-parameters-in-plasma-and-intracellular-of-raltegravir-administered-once-a-da-129998https://curecurrent.com/trials/impact-of-mk-0518-raltegravir-intensification-on-hiv-1-viral-latency-in-patients-with-previous-complete-viral-suppressio-129999https://curecurrent.com/trials/study-to-evaluate-the-influence-of-nevirapine-to-atazanavir-in-steady-state-equilibrium-in-hiv-patients-130000https://curecurrent.com/trials/pilot-opened-randomized-clinical-trial-to-assess-the-efficacy-of-duloxetine-in-the-treatment-of-fibromialgy-in-patients-130001https://curecurrent.com/trials/drug-interactions-between-echinacea-purpurea-and-darunavir-ritonavir-130002https://curecurrent.com/trials/viral-kinetics-of-treatment-with-peginterferon-alpha-2a-ribavirin-and-epoetin-in-patients-coinfected-hcv-hiv-130003https://curecurrent.com/trials/hiv-1-viral-dynamics-in-subjects-initiating-raltegravir-therapy-in-spain-130004https://curecurrent.com/trials/study-to-determine-the-pharmacokinetic-behavior-of-antiretroviral-drugs-in-patients-infected-by-hiv-130005https://curecurrent.com/trials/saquinavir-ritonavir-in-single-therapy-as-maintenance-treatment-130006https://curecurrent.com/trials/immune-response-to-hepatitis-c-virus-130007https://curecurrent.com/trials/treatment-with-tamoxifen-in-cryptococcal-meningitis-130008